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A Introduction 
1. Adipocyte differentiation in obesity 
Obesity is defined as abnormal or excessive fat accumulation which may have adverse 
effects on health1. According to World Health organization, people with a Body Mass 
Index (BMI) of 30 or more are obese (BMI = body weight in kilograms divided by the 
square of body height in metres: kg/m2). More than 2.8 million adults die each year from 
obesity-related diseases such as metabolic syndrome, type 2 diabetes, musculo-
skeletal disorders and cardiovascular diseases1. The increasing prevalence of obesity is 
not only a growing public health problem, but also a policy challenge as its 
consequences have been responsible for 2-8 % of public health service costs2. 
In the pathogenetic chain of events leading to obesity and its systemic complications 
multiple mechanisms of food intake control become important3. Fuel-communicating 
hormones as well as circulating nutrients can be detected by neurons resulting in 
control of food intake, energy expenditure and glucose homeostasis. On adipose tissue 
level the development of obesity involves adipocyte hypertrophy (increase in fat cell 
size), adipogenesis (increase in fat cell number) and angiogenesis (formation of blood 
vessels)4. Adipogenesis is mainly stimulated in times of caloric intake exceeding 
nutritional requirements and includes pre-adipocyte proliferation as well as adipocyte 
differentiation.  
2. Adipocyte differentiation 
2.1  Sequential gene expression during adipocyte differentiation 
Whereas pre-adipocyte proliferation implies the replication of adipocyte precursors, 
adipocyte differentiation includes the transition from fibroblast-like, stellate-shaped 
precursor cells into mature, spherical adipocytes accumulating lipid droplets4. The 
changes in cell shape are accompanied by molecular changes, such as alterations in 
gene expression patterns resulting in an increased ability for lipid synthesis4-6 (Figure 
1). 
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Figure 1: Overview of stages in adipocyte differentiation         
Taken from Gregoire et al.5. 
 
Before differentiation the cells undergo growth arrest as well as at least one round of 
cell doubling. The early stage of differentiation is associated with the disappearance of 
pre-adipocyte marker delta-like 1 homolog Dlk1 (alias pre-adipocyte factor Pref-1). 
Although the mechanism of Dlk1-mediated adipocyte differentiation inhibition remains to 
be elucidated, Dlk1 may possibly function by interacting with extracellular matrix 
proteins or acting as ligand for a pre-adipocyte receptor. Resulting morphological 
changes from fibroblastic to spherical cell shape are paralleled by changes in 
extracellular matrix and cytoskeletal components. ‘CCAAT/enhancer binding protein’ 
C/ebpβ expression increases transiently resulting in ‘peroxisome proliferator-activated 
receptor’ Pparγ expression stimulation. Subsequently C/ebpα is induced whereas the 
expression of C/ebpβ declines again and Pparγ expression is maintained. During 
terminal differentiation C/ebpα and Pparγ transactivate the expression of adipocyte-
specific genes involved in glucose and lipid metabolism to engage lipogenesis. 
Moreover insulin receptor abundance and thus insulin sensitivity increases and the cell 
begins to synthesize adipocyte-secreted products such as leptin thereby representing a 
highly specialized endocrine cell.  
2.2  Stimulatory regulators of adipocyte differentiation 
Much of what is known about regulation of adipocyte differentiation comes from 3T3-L1 
adipocytes, a cell line which has been developed in the 1970s by Green and Kehinde 
from Swiss 3T3 mouse embryos7. 3T3-L1 cells can either stay in pre-adipocyte stadium 
or differentiate after stimulation and the mechanisms for adipogenic conversion as well 
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as their morphological and biochemical characteristics of 3T3-L1 cells have been 
described as similar to those of normal adipocytes in vivo. Moreover these cells have 
several practical advantages over primary preadipocytes4, 5. Firstly, they provide a 
continuous source of cells as they differentiate with high efficiency also after high 
passage numbers, whereas primary adipocytes require a constant fresh supply due to 
their limited lifetime in cell culture. Secondly, 3T3-L1 cells are a homogenous 
population, all in the same stage of differentiation and thirdly they can be used for the 
study of both, early and late adipogenic events. An advantage of primary pre-
adipocytes is that they can be isolated from adipose tissue of various species, at 
different postnatal stages of development and from various anatomic locations4, 5. 
In vitro studies have uncovered the mechanisms that drive the adipogenic process, 
involving extracellular signals such as nutrient sufficiency, cAMP elevating agents, 
hormonal and paracrine regulators4-6. 3T3-L1 cells for example can differentiate into 
mature adipocytes in high-glucose growth medium after stimulation with a combination 
of agents including ‘isobutyl-methylxanthine’ IBMX, dexamethasone and insulin4. 
Isobutyl-methylxanthine IBMX enhances adipocyte differentiation by increasing 
intracellular cAMP levels resulting in increased C/ebpβ expression. Just like hormones 
in general, insulin and dexamethasone also mediate adipogenic effects by inducing 
transcription of adipogenic genes via specific receptors. Insulin stimulates Pparγ 
expression via Igf-I receptor activation whereas the synthetic glucocorticoid 
dexamethasone up-regulates C/ebpδ via glucocorticoid receptor activation. The most 
essential paracrine signaling molecule ‘insulin-like growth factor’ Igf-I is secreted by 
expanding adipocytes and shares its mechanism with insulin. Further, nutrient 
sufficiency, such as high glucose levels induces adipocyte differentiation by increasing 
C/ebpα and Pparγ levels. 
3. mTOR nutrient signaling 
Various nutrient-signaling pathways are responsible for adapting cell differentiation as 
well as cell growth to nutrient availability towards maintenance of whole-body metabolic 
homeostasis8. Among these, the mechanistic target of rapamycin (mTOR) pathway is 
an evolutionary conserved and well-studied intracellular nutrient-signaling pathway 
involved in the regulation of adipocyte differentiation, lipogenesis and intracellular 
accumulation of triglycerides8, 9. mTOR itself is a multifunctional protein kinase 
consisting of two distinct complexes, termed mTOR complex 1 (mTORC1) and mTOR 
complex 2 (mTORC2) differing in their protein composition. mTORC1 consists of the 
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catalytic subunit mTOR, the positive mTOR regulator GβL and ‘regulatory associated 
protein of mTOR complex 1’ Rptor, which is involved in substrate recognition. mTORC2 
includes mTOR, GβL and ‘Rptor independent companion of mTOR complex 2’ (Rictor). 
By integrating sufficiency of nutrients, energy and oxygen as well as signals from 
growth factors and hormones, the mTOR pathway regulates various cellular processes 
affecting cell growth and differentiation (Figure 2). 
 
Figure 2: Simplified scheme of mTOR pathway 
 
3.1  Upstream regulators of mTOR 
In mammals both TOR complexes are controlled by growth factors and hormones 
whereas only mTORC1 responds to nutrients, energy stress and hypoxia10-12. Insulin 
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and Igf bind to their receptors, which in turn activate key transduction pathways such as 
the insulin or the MAPK signaling pathway. In case of activated insulin signaling 
‘phosphatidylinositol 3-kinase’ Pi3k is stimulated leading to phosphorylation of 
‘thymoma viral proto-oncogene’ Akt. MAPK signaling cascade in the end stimulates 
‘ribosomal protein S6 kinase‘ Rsk. Both cascades result in mTORC1 stimulation via 
‘tuberous sclerosis complex’ (Tsc) inhibition. Tsc includes Tsc1 (alias hamartin) and 
Tsc2 (alias tuberin) forming a physical and functional complex which acts via Rheb as 
an important negative regulator of mTORC1. However, Akt can also promote mTORC1 
activity in a Tsc-independent manner. mTORC2 responds to growth factors through a 
Pi3k-dependent mechanism, which is poorly defined. 
Nutrients, energy stress and hypoxia control mTOR signaling only via mTORC1. Firstly 
it has long been known that re-addition of amino acids, such as leucine, to starved cells 
can strongly stimulate mTORC1 activity, but the mechanism behind is not yet fully 
understood. Secondly, since cell growth is an energy-intensive process, mTOR nutrient 
signaling is also regulated by an energy sensor. Ampk is activated by increased 
intracellular AMP or ADP levels that can occur during energy stress. Ampk activation 
can also be triggered by Cab39, which in turn is also activated under conditions of 
energy stress. Ampk then blocks mTORC1 signaling via Tsc2 or Rptor. Thirdly, cellular 
metabolism is dependent on sufficient oxygen. Hypoxia inhibits mTORC1 by inducing 
Ddit4 expression, which in turn activates mTORC1 inhibitor Tsc.  
3.2  Cellular processes downstream of mTOR 
mTOR senses these upstream signals in order to control various components of the 
translation machinery, angiogenesis and regulation of autophagy10-12. Protein synthesis 
is adapted to nutrient availability through translation initiation of a subset of genes via 
phosphorylation of S6k1 and 4Ebp1. mTORC1-mediated S6k1 phosphorylation of 
Thr389 results in phosphorylation of translation initiation factors and RNA binding 
proteins such as eIF4b thereby driving efficient translation. mTORC1-mediated 4Ebp1 
phosphorylation prevents its inhibitory activity by leading to dissociation from eIF4e 
thereby allowing initiation of translation. Via a widely unknown mechanism, mTORC1 
activates the translation of many lipogenic genes such as fatty acid synthase. 
Experiments especially in the cancer field of mTOR-research show that tissue growth 
beyond a certain size is dependent on angiogenesis and that mTOR serves as a central 
regulator13. Stimulated by hypoxia, mTORC1 increases ‘vascular endothelial growth 
factor’ (Vegfa) gene expression via Hif1-a14. 
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Focused on the positive effects on anabolic processes so far, mTOR also promotes 
growth by negatively regulating autophagy. Therefore mTORC1 directly suppresses 
‘unc-51 like autophagy activating kinase’ Ulk, a kinase complex required to initiate 
autophagy.  
Until today it has been well established that mTOR plays an important role in adipocyte 
differentiation11, 15. mTOR signaling regulates adipocyte differentiation mainly by 
adjusting the cellular biosynthetic capacity to nutrient availability. On the one hand it 
has been shown that mTORC1 overactivation stimulates adipogenesis. On the other 
hand rapamycin-mediated mTORC1 inhibition down-regulates transcription factors such 
as C/ebpα and Pparγ thereby decreasing the translation of proteins critical for 
adipogenesis. Whereas 4Ebp1 controls terminal differentiation via the master regulator 
Pparγ, mTOR effector S6k1 regulates the expression of early adipogenic transcription 
factors. The mTORC1-mediated effect on adipogenesis has also been confirmed in 
vivo. Mice with adipose-specific loss of mTORC1 are lean animals with fewer and 
smaller adipocytes being resistant to high fat diet-induced obesity16. In vivo studies in 
humans showed that chronic nutrient overload activates mTOR signaling and leads to 
insulin resistance17, whereas inhibiting TOR-signaling in Drosophila blocks metabolic 
and cardiotoxic phenotypes caused by high fat diet18.  
3.3  mTOR inhibition by rapamycin 
In the early 1990s mTOR has been discovered as the physical target of rapamycin 
(alias sirolimus), a macrolide with anti-proliferative properties which has first been 
isolated from a soil sample of Rapa Nui island11, 19. Rapamycin, which is produced by 
Streptomyces hygroscopicus, acts by complexing with the highly conserved 
immunophilin ‘FK506 binding protein 12’ (Fkbp12). Subsequently Fkbp12 binds and 
inhibits mTORC1, whereas mTORC2 acts rapamycin insensitive. 
In clinical practice, rapamycin and its derivatives are mainly used in transplant patients 
due to their immunosuppressive activity. During treatments, weight loss which appears 
to be mTOR-associated has been observed in kidney transplant and kidney disease 
patients20, 21. Nevertheless in vivo application of rapamycin and its derivatives in obese 
subjects for the purpose of inhibiting nutrient-driven mTOR overactivation and adipocyte 
differentiation is precluded by associated unfavorable side-effects on pancreatic islet 
cells, glucose homeostasis and insulin resistance22-24. Another disadvantage is that, 
after initial inhibition, 4Ebp1 becomes rapamycin-resistant in cells subjected to high 
dose or chronic rapamycin exposure resulting in sustained protein translation25. 
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4. miRNAs in gene regulation 
4.1  Biology of miRNAs 
Whole genome sequencing in mammals revealed that 98 % of genetic material is non-
coding RNA, which in part is involved in gene regulation26, 27. MicroRNAs (miRNAs) are 
a group of highly conserved, 18-25 bp long noncoding RNAs that regulate gene 
expression in animals and in plants28-30. The first miRNA, namely lin-4, was discovered 
in 1993 in Caenorhabditis elegans by Victor Ambros and colleagues as a regulator of 
developmental timing. Ambros and Ruvkun groups noticed sequence complementarity 
between the short RNA product encoded by the lin-4 gene and the 3´-UTR of lin-14 
mRNA. Further they described that this complementarity was necessary for LIN-14 
protein translational inhibition and thereby discovered a new mechanism of gene 
regulation. In the following years growing numbers of small RNAs with regulatory roles 
were discovered and in 2001, this class of RNAs was termed ‘microRNAs’. Until now, 
more than 1,800 human and 1,100 murine miRNAs have been identified (miRbase 
version 20). With the discovery of more of their respective targets and regulatory 
functions, the enormous biological impact of miRNA-mediated gene regulation became 
evident. MiRNAs are estimated to influence at least 30 % of genes in the human 
genome and it has been described that single miRNAs can control whole signaling 
cascades by targeting few key regulatory molecules within a given pathway31. As 
functional consequences miRNAs were shown to play major roles in a variety of 
biological processes and diseases including cell differentiation, proliferation and growth, 
apoptosis and cancer.  
4.2  MiRNA biogenesis and mechanism of action 
MiRNAs control gene expression post-transcriptionally through partial base-pairing with 
their target mRNAs, which leads to mRNA degradation or repression of translation28-30 
(Figure 3).  
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Figure 3: Current model for the biogenesis and post-
transcriptional suppression of miRNAs 
(from He et al., Nature reviews30). 
 
Initially miRNAs are transcribed from their own genes, which are mainly found in 
intergenic regions or introns of protein-coding genes. The primary transcript of a miRNA 
gene (pri-miRNA) typically contains one or more hairpin structures and an imperfectly 
paired stem of approximately 30 bp with flanking 5’- and 3’-single stranded ends. The 
unique pri-miRNA structures are recognized and processed by the ribonuclease Drosha 
resulting in a RNA hairpin called pre-miRNA. While this pri-miRNA processing occurs in 
the nucleus, the nucleo/cytoplasmic transporter Exportin-5 (Exp-5) then transfers the 
pre-miRNA into the cytoplasm. Once inside the cytoplasm the pre-miRNA is cleaved by 
another ribonuclease complex called Dicer leading to miRNA:miRNA* duplex formation. 
The mature miRNA strand of the duplex is then incorporated into the ‘RNA-induced 
silencing complex’ RISC and induces target recognition whereas its complementary 
miRNA* strand is released and degraded. The subsequent recognition of target mRNAs 
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is based on the sequence complementarity of nucleotide positions 2–7 of the miRNA 
(named seed sequence) to its binding site, mostly located in the 3’UTR of a target gene. 
If perfect complementarity leads to target mRNA cleavage and central mismatches lead 
to repression of translation is an ongoing debate. However, miRNA-mediated mRNA 
degradation seems to be based on de-capping, de-adenylation and exonucleolytic 
digestion, whereas translation inhibition is poorly understood and may involve multiple 
mechanisms, such as inhibition of translation initiation and translation inhibition at the 
post-initiation stage28-30.  
Interestingly, a study in humans showed that 37 % of the known miRNA genes appear 
in clusters of two or more miRNAs28, 32. These miRNAs derive from a common multi-
cistronic pri-miRNA and sometimes even show high sequence similarity. Clustered 
miRNAs are influenced by similar regulation mechanisms and thus they may regulate a 
common set of target mRNAs resulting in a functional relationship.  
Further many mammalian miRNA genes were found to have paralogues that derived 
from gene duplication thereby forming miRNA families. Since paralogues often have 
identical seed sequences they may act redundantly33. 
4.3  MiRNAs in adipogenesis and nutrient sensing 
Several high throughput studies have identified a number of miRNAs, which are de-
regulated during mouse adipogenesis and some have also been experimentally 
validated as regulators of 3T3-L1 adipocyte differentiation34. These include miR-143, 
miR-103 and cluster 17/92, which increase triglyceride accumulation and/or 3T3-L1 
differentiation as well as miR-27a, let-7, miR-15a and miR-448, which attenuate 3T3-L1 
differentiation. The mTOR pathway is well-characterized as a nutrient signaling pathway 
regulating cell differentiation. So far, however, only 3 miRNAs, namely miR-99a, -100 
and -199a* have been confirmed to regulate mTOR signaling in the context of cancer 
and dermal wound healing35-38. Thus the pattern of miRNA regulation involved in mTOR 
signaling during adipocyte differentiation is not yet fully elucidated. A study of our group 
experimentally identified a set of mTOR-associated miRNAs and provides a list of their 
in silico predicted target genes within the mTOR pathway39. 
Some miRNAs, such as miR-103 and miR-107 were shown to play a role in obesity and 
its associated pathologies34, 40. This knowledge has been transferred to treat e.g. 
hypercholesterolemia and liver steatosis in mice41, thereby demonstrating that miRNAs 
can provide a promising target class for novel therapeutic options.  
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5. Aims of the thesis 
Understanding the molecular basis of nutrient-driven adipogenesis is essential to 
identify and monitor new therapeutics, either by drugs or diets that could ameliorate the 
adverse sequels of obesity. The identification of specific targets that exert rapamycin-
like effects on nutrient signaling might provide an approach to search for alternative 
therapeutic options. In this study, we specifically aimed at identifying distinct miRNA-
target pairs that are associated with the inhibition of adipogenesis via mTOR nutrient 
signaling. Specifically, the present study aimed at experimentally confirming selected 
miRNA-target pairs within the mTOR nutrient signaling pathway and at investigating 
candidate miRNAs’ influence on adipocyte differentiation via the mTOR pathway. 
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B Material and Methods 
1. Material 
1.1 Sources of chemicals, reagents and enzymes 
AppliChem, Darmstadt, Germany 
Albumin Fraction V pH 7.0, NaN3 
Applied Biosystems, Carlsbad, USA  
Nuclease-free water, Power SYBR® Green Mastermix, TaqMan® Universal PCR Master 
Mix 
Aventis, Sanofi, Paris, France 
Insulin Insuman rapid (40 I.E./ml) 
Calbiochem®, Merck, Darmstadt Germany 
Glycerol, Phosphatase Inhibitor Cocktail Set II, Protease Inhibitor Cocktail Set III 
Carl Roth, Karlsruhe, Germany 
Agar-Agar, Ampicillin, Bromphenol Blue, Isopropanol (≥99.8 %), MgSO4, ATP, 
(MgCO3)4Mg(OH)2, MgSO4, sodium acetate, Tricine, Tris, Tween20 
Fermentas, Waltham, USA  
dNTPs, Gene RulerTM 1 kb DNA Ladder,NotI restriction enzyme (Buffer 0), PfuDNA 
Polymerase (Pfu buffer without MgSO4), T4 DNA ligase (T4 DNA ligase buffer) 
GIBCO, Carlsbad, USA 
FBS 
Invitrogen, Carlsbad, USA 
Agarose, PBS, LipofectamineTM2000, DMSO      
Merck, Darmstadt, Germany 
NaCl 
New England Biolabs, Beverly, USA 
ApaLI restriction enzyme (NEBuffer 4), AsiI restriction enzyme (NEBuffer 4) 
PAA Laboratories GmbH, Pasching, Austria 
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Antibiotic-antimycotic solution, DMEM (4.5 g/L glucose, with L-Glutamin), Trypsin-EDTA 
(10x)   
pjk, Kleinblittersdorf, Germany 
Coenzym A, DTT 
Qiagen, Hilden, Germany 
Qiazol Lysis Reagent  
Serva, Heidelberg, Germany 
rapamycin stock (0.92mg/ml in DMSO) 
Sigma-Aldrich, St. Louis, USA 
7-AAD, Chloroform (>99 %), Dexamethasone 98 %, DMSO, EDTA, IBMX (1 M), LB 
Agar, Oil Red O stock (5 mg/ml), SDS, Triton X-100, Trypan Blue, 25 % glutaric acid 
SynChem, Illinois, USA 
coelenterazine, D-Luciferin 
Thermo Fisher Scientific, Waltham, USA 
RestoreTM PLUS Western Blot Stripping Buffer 
 
1.2 Buffers and solutions 
 
Flow cytometry Buffer 2 % FBS   
0.02 % NaN3 
ad PBS 500 ml 
 
Laemmli Buffer 6x 0.5 M SDS   
0.6 M DTT   
0.4 M Tris   
0.9 mM Bromphenol Blue 
9 M Glycerol   
ad H2O bidest. 50 ml              pH 6.8 
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Lysis Buffer 10x 0.3 M Tris   
20 mM Triton X-100 
ad H2O bidest. 400 ml              pH 7.4 
 
TBS-T Buffer 10x 0.2 M Tris   
0.8 mM Tween20 
1.4 M NaCl 
ad H2O bidest. 1 l                     pH 7.6 
 
TNT Lysis Buffer 10x 0.2 M Tris   
0.8 mM Tween20 
1.4 M NaCl 
ad H2O bidest. 1 l                     pH 7.4 
 
 
Coelenterazine solution 5x 0.05 mM Coelenterazine  
(24 mM stock solution in MeOH)   
ad H2O bidest. 1 l 
 
D-Luciferin solution 0.5 mM D-Luciferin 
0.3 mM Coenzym A 
33 mM DTT 
0.6 mM ATP 
1 mM (MgCO3)4Mg(OH)2 
5 mM MgSO4 
20 mM Tricine 
0.1 mM EDTA   
ad H2O bidest. 1 l 
 
5 % BSA solution 5 g Albumin Fraction V 
ad TBS-T buffer 1 l                  pH 7.0 
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0.5 % glutaric acid solution 0.5 g glutaric acid   
ad PBS 1 l 
 
Oil Red O solution 7.3 mM Oil Red O 
ad H2O bidest. 1 l 
 
Rapamycin solution 10 mM rapamycin   
ad DMSO 1 ml 
 
 
Sodium acetate solution 3 M sodium acetate   
ad H2O bidest. 100 ml            pH 5.2 
 
 
1.3 Plasmids and oligonucleotides 
 
Ambion, Carlsbad, USA 
Pre-miRTM miRNA Precursors, Pre-miRTM Negative Control #1, Anti-miRTM miRNA 
Inhibitors, Anti-miRTM Negative Control #1 
Applied Biosystems, Carlsbad, USA 
TaqMan® MicroRNA Assays 
Invitrogen, Carlsbad, USA 
pCR®_XL_TOPO® vector 
Promega, Wisconsin, USA 
psiCHECKTM-2 vector (Figure S 1)  
Qiagen, Hilden, Germany 
AllStars Negative Control siRNA AF488 
 MATERIAL AND METHODS 
 
 
15 
Table 1: Oligonucleotide primer sequences and the respective cycling conditions 
and product sizes 
Primers were designed using Primer3 software and synthesized by Metabion, 
Martinsried, Germany. Efficiency and specificity were tested for all primer pairs before 
use. 
Gene Sequence 5‘ → 3‘ Optimal 
conditions 
Size 
(bp) 
Pparγ 
CAG CAT TTC TGC TCC ACA CTA TGA AG 40 cycles 
60.0°C 388 AGC AAG GCA CTT CTG AAA CCG 
Dlk1 
GAC CCA CCC TGT GAC CCC 40 cycles 
60.0°C 757 CAG GCA GCT CGT GCA CCC C 
Pik3r1 
CCA AGC CCA CTA CTG TAG CC 45 cycles 
60.0°C 171 TGT AAT CGC CGT GCA TTT TA 
Pik3r3 
TGA TGA TGC CCT ATT CGA CA 45 cycles 
60.0°C 189 CCC GCA ATT TGT CAT TTA CC 
Tsc1 
CAAGCACCTCTTCTGCCTTC 45 cycles 
60.0°C 194 GTCACATGGCCTGGTTTCTT 
Ppib 
TCC GTC GTC TTC CTT TTG 40/45 cycles 
60.0°C 160 CCA CTG TTT TTG GAA CAG TCT 
Vegfa 
GTA CCT CCA CCA TGC CAA GT 40 cycles 
60.0°C 183 ACA CAG GAC GGC TTG AAG AT 
Pik3r1  
3’UTR 
Pho GTA GCGATCGC CTGCCCTCGGATCCAGTT 45 cycles 
63.7°C 4,100 GTA GCGGCCGC TTTTAAGTTTCAAAACAACCTTTATTC 
Pik3r3  
3’UTR 
Pho GTA GCGATCGC GCAGAGTGGAAGAGACACGCT 45 cycles 
65.6°C 3,200 GTA GCGGCCGC TTCACTGCAATGTCTTTATTGCATC 
Tsc1  
3’UTR 
Pho GTA GCGATCGC GGTCTGTCAGTGTTCATTTGC 45 cycles 
57.7°C 4,000 GTA GCGGCCGC GCAAAACAATAAATCTTTATTTGTTCA 
 
1.4 Antibodies 
Cell Signaling Technology, Danvers, USA 
AKT1 (C73H10), α-tubulin (11H10), Hamartin/TSC1 (D43E2), p70 S6 Kinase (49D7), 
Phospho-p70, S6Kinase (Thr389), PI3 Kinase p85 (19H8) 
Thermo Fisher Scientific, Waltham, USA 
RSK3   
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1.5 Commercial kits 
Applied Biosystems, Carlsbad, USA  
TaqMan® MicroRNA RT Kit 
BioRad, Hercules, USA  
Immun-StarTM HRP Chemiluminescent Kit  
Macherey-Nagel, Düren, Germany 
NucleoSpin® Extract II Kit  
Thermo Fisher Scientific, Waltham, USA 
Pierce® BCA Protein Assay Kit  
Qiagen, Hilden, Germany 
miRNeasy® Mini Kit, QIAprep® Miniprep Kit, QuantiTect® Reverse Transcriptase Kit  
1.6 Cell lines 
Invitrogen, Carlsbad, USA 
ElectroMAXTM DH10BTM cells 
LGC Standards, Teddington, UK 
HEK-293 cells (ATCC® CRL-1573™), 3T3-L1 cells (ATCC®CL-173TM) 
1.7 Consumables 
Applied Biosystems, Carlsbad, USA  
MicroAmp optical 96-well reaction plates 
BioRad, Hercules, USA  
GenePulser® electroporation cuvette 
Corning, New York, USA 
Corning® 175 cm2 Flask, Costar® 6-well cell culture plate     
Eppendorf, Hamburg, Germany 
PCR Tubes 0.2 ml, Safe-Lock Tubes 1.5 ml, Safe-Lock Tubes 2.0 ml 
GE Healthcare, Little Chalfont, UK 
Amersham HybondTM-P PVDF Membrane  
Thermo Fisher Scientific, Waltham, USA  
LumiNunc F96, NunclonTM Surface 24-well plates, NunclonTM Surface 96-well plates 
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1.8 Equipment and software 
Applied Biosystems, Carlsbad, USA 
7900HT Fast Real-Time PCR System, SDS software 2.3 2005 
Becton Dickinson, San Jose, USA 
BD FACSCantoTM Flow Cytometer, BD FACSDivaTM software v. 5.0.3 
BioRad, Hercules, USA 
Gene Pulser II, mini‐PROTEAN® Tetra System 
BMG Labtech, Ortenberg, Germany 
FluoStar OPTIMA luminometer, FluoStar OPTIMA software 
BSRC Alexander Fleming, Athens, Greece  
DIANA-miRPath v.1.0 
Eppendorf, Hamburg, Germany 
Thermomixer comfort 
GraphPad Software, San Diego, USA  
GraphPad PRISM® v. 5.0.1 
Innovatis, Bielefeld, Germany 
Cellscreen  
Leica Microsystems, Wetzlar, Germany 
Leica DMIL microscope 
Microsoft, Redmond, USA  
Microsoft Office Professional Plus 2010 
New Brunswick Scientific, Nürtingen, Germany 
Excella E24 Incubator Shaker 
NIH, Maryland, USA  
ImageJ 
PEQLAB Biotechnologie GmbH, Erlangen, Germany 
96 Universal Gradient peqSTAR 
Qiagen, Hilden, Germany 
QIAcube RNA Purification roboter 
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Scientific Industries, New York, USA 
Vortex Genie 2 
Thermo Fisher Scientific, Waltham, USA 
HERAcell 240 incubator, Heraeus Fresco 17 Centrifuge, Nanodrop® MD-1000 
Universität Düsseldorf, Düsseldorf, Germany  
Ligation Calculator 
Whitehead Institute for Biomedical Research 
Primer3 v. 0.4.0 
2. Methods 
2.1 In silico target prediction 
Prediction of direct miRNA targets was performed using five prediction programs: PITA, 
miRanda, targetScanS, pictar and targetspy. Targets with consensus target prediction 
of at least 2 algorithms were considered predicted. Because of the similarity of their 
seed sequences, miRNAs belonging to the same family were grouped. For pathway 
enrichment analysis, DIANA-miRPath (v.1.0) software was used applying PicTar 4-way 
and TargetScan 5 algorithms42. 
2.2 Luciferase reporter assay 
3’UTR amplification 
3’UTRs of the target genes Pik3r1, Pik3r3 and Tsc1 were PCR-amplified according to 
following experimental protocols (Table 2). 
Table 2: Thermal cycling conditions for 3'UTR amplification of target genes 
Pik3r1, Pik3r3 and Tsc1 
95 °C 10 min Initial denaturation  
95 °C 30 s Denaturation 
45 
cycles 
63.7°C (Pik3r1) 65.6°C 
(Pik3r3) 72.0°C (Tsc1) 30 s Primer annealing 
72 °C 4 min 30 s Elongation 
72 °C 10 min Final elongation  
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Amplification was performed using primer pairs spanning complete 3’UTRs (primer 
sequences are given in section 0) and Pfu DNA Polymerase on a 7900HT 
FastRealTime PCR Cycler and analyzed using SDS software 2.3 2005. 
Table 3: Optimized reaction setups for 3'UTR amplification of target genes Pik3r1, 
Pik3r3 and Tsc1 
volume [µl] reagent final 
concentration 
2.5 µl Pfu Buffer without MgSO4 (10x) 1x 
1 µl dNTPs (10 mM) 2.5 mM 
1 µl BSA  (100x) 4x 
3 µl (Pik3r1, Pik3r3)  
2 µl (Tsc1) 
MgSO4  
(25 mM) 3 mM/2 mM 
2 µl Pfu DNA Polymerase  (2.5 U/µl) 5 U 
0.5 µl Primer fwd (100 µM) 2 µM 
0.5 µl Primer rev  (100 µM) 2 µM 
2 µl (Pik3r1, Tsc1)  
3 µl (Pik3r3) 
mouse genomic DNA  
(80 ng/µl) 160ng/240 ng 
12.5 µl (Pik3r1)  
11.5 µl (Pik3r3)  
13.5 µl (Tsc1) 
nuclease-free water  
 
Cloning 
Amplified 3’UTRs of Pik3r1, Pik3r3 and Tsc1 were purified by excision from  agarose 
gel using NucleoSpin® Extract II Kit and cloned into pCR®_XL_TOPO® vector followed 
by sub-cloning into psiCHECKTM-2 vector (Figure S 1). TOPO TA cloning® is a one-step 
cloning strategy for the direct insertion of PCR-products into pCR®_XL_TOPO® vector 
without digestion or ligation reactions. TOPO TA cloning® was performed according to 
manufacturer’s instructions. For subsequent cloning into the NotI and AsiI restriction site 
of psiCHECKTM-2 vector, restriction enzyme digestions were performed using 5 µl of 
specific 10x buffer, 0.5 µl 100x BSA, 0.2 µl of enzyme (10 U/µl) and 1-2 µg DNA in a 
50 µl reaction volume. Digestions were run at 37°C for at least 4 h and then cleaned-up 
using NucleoSpin® Extract II Kit. Complete 3´-UTRs were ligated into 100 ng 
psiCHECKTM-2 reporter plasmid using T4 DNA ligase (5 U/µl) following manufacturer´s 
instructions. Exact amounts of inserts were determined by “ligation calculator software” 
calculating the exact volumetric ratio (1:3) between vector and insert in the ligation 
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reaction. In order to verify the identity of the cloned insert, digestions using ApaLI 
according to manufacturer’s guidelines were set up for an analytical agarose gel. To 
purify and concentrate vector constructs, chloroform precipitation was used as 
described in section B 2.5. 
In order to amplify the vector constructs electrocompetent E.coli cells were transformed 
by electroporation. For this purpose, 2 µl of electrocompetent E.coli were added to 50 
and 100 ng plasmid vector in 50 µl nuclease-free water. The mixtures were transferred 
to a pre-cooled GenePulser® electroporation cuvette and transformation was performed 
on a Gene Pulser II using the following conditions: 1,800 V, 100 Ω, 25 µF. The mixtures 
were pipetted into pre-warmed LB medium directly after electroporation and incubated 
at 37°C for 1 h, followed by centrifugation at 4,000 rpm for 4 min. Subsequently the 
supernatant was discarded and the pellet was resuspended in the remaining liquid. 50 
µl and 100 µl of resuspension was spread on LB-Amp100 agar plates (15 g Agar-Agar in 
1 l LB medium) and cultured at 37°C overnight. Formed colonies were picked and 
transferred to 5 ml LB-Amp100 overnight cultures incubated at 37°C. For plasmid 
purification QIAprep® Miniprep Kit was applied following manufacturer´s instructions. 
Clones were verified by control digestion with ApaLI.  
Measurement of reporter gene expression 
Direct interaction between the candidate miRNAs and the 3´-UTRs of the predicted 
target genes Tsc1, Pik3r1 and Pik3r3 was examined by luciferase-based reporter 
assays. Therefore HEK-293 cells, cultured in DMEM (4.5 g/L glucose, with L-Glutamin) 
supplemented with 10 % heat-inactivated FBS and 1 % antibiotic-antimycotic solution in 
24-well plates, were transfected using Lipofectamine2000 according to the 
manufacturer’s instructions. 20 pmol of the respective Pre-miRTM miRNA Precursor or 
negative control #1 and 100 ng of the reporter vector-3’UTR constructs were co-
transfected per well.  
In case of effective silencing by the respective miRNAs Renilla luciferase activity is 
reduced due to the adjacently inserted 3’UTR. Firefly luciferase activity was used as a 
control for transfection efficiency. Renilla luciferase activity was quantified using 
coelenterazine as substrate whereas firefly luciferase activity was quantified by addition 
of its substrate luciferin. Therefore cells were lysed 72 h after transfection by addition of 
120 µl lysis buffer per well and incubated for 10 min at room temperature with constant 
agitation. Using a white 96-well plate, 100 µl of the respective substrate solutions were 
added automatically to 50 µl of lysed sample and luminescence was measured by 
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FluoStar OPTIMA luminometer. Background luminescence was subtracted for each well 
by FluoStar software. Subsequently, Renilla luciferase activity was normalized to firefly 
luciferase activity for each sample. Luciferase assay was performed in two independent 
experiments each performed in triplicates. 
2.3 Transfection experiment 
Culture of 3T3-L1 adipocytes 
For transfection and differentiation experiments, 3T3-L1 cells were pre-cultured in 
DMEM (4.5 g/l glucose) supplemented with 10 % heat-inactivated FBS and 1 % 
antibiotics/antimycotics at 37°C and 5 % CO2 under standard conditions. Detachment of 
cells was achieved by addition of 2 ml Trypsin-EDTA (0.05 % (w/v) Trypsin and 0.5 mM 
EDTA) per 175 cm2 cell culture flask and subsequent incubation for 4 min at 37°C. As 
soon as detachment was visible, cell culture medium was added to stop the enzymatic 
reaction. 
Transfection 
For transfection, cells were seeded in 24-well plates (80,000 cells per well). After 24 
hours cells reached confluence and transfection was performed using 
Lipofectamine2000 following manufacturer´s instructions. 20 pmol of the respective Pre-
miRTM miRNA Precursors and or Anti-miRTM miRNA Inhibitors were transfected. Cells 
transfected with Pre-miRTM miRNA Precursor Negative Control #1 or Anti-miRTM miRNA 
Inhibitor Negative Control #1 were used as control. 
Cell harvest 
After 3 days, cells were harvested by adding 200 µl Qiazol Lysis Reagent and 
incubated at 37°C for 2 minutes. Four independent experiments were performed, with 
each treatment done in 6 replicates, which were pooled. RNA was isolated and miRNA- 
as well as mRNA levels were quantified as described in section B 2.5. Harvesting of 
cells for immunoblots is described in section B 2.6. 
2.4 Differentiation experiment 
Cell culture and transfection  
3T3-L1 adipocytes were pre-cultured as for transfection experiments. For differentiation 
experiments, cells were seeded in 6-well plates (250,000 cells/well). After 24 hours cells 
were transfected with 80 pmol pre-/anti-miRNAs using Lipofectamine2000 as described 
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in section B 2.3. Cells transfected with negative control pre-/anti-miRNAs were used as 
control. 
Differentiation 
Two days after transfection, differentiation was initiated (designated as day 0) by the 
addition of 200 nM insulin, 1 µM dexamethasone and 0.5 mM IBMX to growth medium. 
After 3 days cells were further grown in growth medium supplemented with 200 nM 
insulin and medium was changed again at day 5. A rapamycin concentration of 20 nM 
directly added to the medium was used for inhibition of 3T3-L1 adipogenic 
differentiation. Cells were visually monitored for viability during the whole procedure. 
Cell harvest 
Cells were harvested at day 0, day 3 and day 6 of differentiation by the addition of 
750 µl Qiazol Lysis Reagent per well. Two independent experiments were performed, 
each measured in technical triplicates. RNA was isolated and miRNA- as well as mRNA 
levels were quantified as described for transfection experiments.  
Lipid droplet quantification 
Oil Red O staining of 3T3-L1 adipocytes was performed following the procedure 
described by Green and Kehinde43 with minor modifications. Briefly, cells were washed 
with PBS and fixed in 0.5 % glutaric acid solution for 5 min. Cells were washed twice 
with PBS followed by a wash step with 60 % isopropanol. Cells were stained in freshly 
prepared Oil Red O solution for 1 h. After staining, the cells were subsequently washed 
with 60 % isopropanol and PBS. Quantification of lipid droplet size (µm2) and number 
was evaluated optically by light microscopy at day 6 of differentiation using a digital 
image analysis approach as previously described44. For this purpose, Oil Red O stained 
cell images were thresholded for the lipid droplet signal via imaging software ImageJ. In 
order to identify single droplets and separate overlapping droplets the image was 
subjected to watershed object separation. Data were exported and analyzed using 
Microsoft Excel software. 
In a second confirmatory approach, lipid droplets were quantified by an absorbance 
based method. Therefore cells were de-stained with 100 % isopropanol for 30 minutes 
and the Oil Red O content in the supernatant was measured by FluoStar OPTIMA 
luminometer. Absorbance was normalized to the percentage of well area covered by 
cells as determined using Cellscreen automated microscopy. 
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2.5 RNA/DNA analysis 
Isolation of total RNA including small RNAs 
For total RNA-isolation, 3T3-L1 cells were lysed directly by adding QIAzol Lysis 
Reagent. Lysates were transferred into a microcentrifuge tube and cooled on ice until 
RNA was isolated with miRNeasy Mini Kit and QIACube RNA Purification roboter 
according to manufacturer’s instructions.  
Chloroform precipitation for DNA purification 
Vector constructs were purified and concentrated after ligation reaction as followed: An 
equal volume of chloroform was added to the sample and the tube was mixed 
vigorously until an emulsion was formed. The aqueous phase was transferred to a fresh 
tube, while the organic and interphase were discarded. For DNA precipitation 0.3 M 
final concentration of sodium acetate pH 5.2 and two volumes of 100 % ethanol were 
added. Samples were incubated at -20°C for 1 h and subsequently centrifuged at 4°C 
for 30 min. After removal of the supernatant, the pellet was washed once with 70 % 
ethanol, air-dried and resuspended in 10-50 µl aqua ad injectabilia.  
RNA Quality testing 
RNA quality and concentration was determined by absorbance measurement. 
Acceptable values were defined as 260/280 nm ratios above 2.0 and 260/230 nm ratios 
above 1.0. In addition, RNA integrity was analyzed by native agarose gel 
electrophoresis. Therefore, 1-3 µg RNA was denatured at 85°C for 3 min. After cooling 
on ice and addition of 2 µl loading dye, samples were loaded on a 0.8 % agarose gel in 
TAE buffer with 0.5 µg/ml ethidium bromide added to the gel and run at 75 V. 
miRNA analysis 
For miRNA quantification, RNA was reverse transcribed and subjected to real-time PCR 
(rt-PCR) analysis. Therefore cDNA synthesis from 50 ng total RNA was performed 
using TaqMan® MicroRNA RT Kit (Applied Biosystems) and TaqMan® MicroRNA Assay 
RT Primer according to manufacturer’s instructions on a 96 Universal Gradient 
peqSTAR. Components for subsequent rt-PCR reaction were 3.3 ng cDNA, 1x 
respective TaqMan® MicroRNA Assay PCR Primer and 1x TaqMan® Universal PCR 
Master Mix. Total reaction volume was 15 µl. Reactions were run in triplicates on a 
7900HT Fast Real-Time PCR System (Applied Biosystems) following the thermal profile 
in Table 4. “Non-template” controls were included. 
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Table 4: Thermal cycling conditions for miRNA quantification 
95 °C 3 min Initial denaturation  
95 °C 15 s Denaturation 
45 cycles 
60 °C 1 min Primer annealing & elongation 
95 °C 10 min Final denaturation  
 
Small nucleolar RNAs (snoRNAs) are commonly used reference genes for miRNA 
expression analyses45. Two different snoRNAs, namely sno-202 and sno-234 were 
tested in the present experimental settings. Sno-202 showed more stable transcriptional 
expression and thus was used as reference gene. Relative quantification was 
calculated by ∆∆CT-method46. 
mRNA analysis 
For relative quantification of gene expression, RNA was reverse transcribed and 
quantified by real-time PCR analysis. Therefore 400 ng total RNA were reverse 
transcribed on a 96 Universal Gradient peqSTAR using QuantiTect® Reverse 
Transcriptase Kit following manufacturer’s instructions. For rt-PCR, 25 µl-reactions 
consisting of 1 µl cDNA, 500 nM forward and reverse primer (Table 1), 12.5 µl 2x 
Power SYBR® Green Mastermix containing SYBR® Green I Dye, AmpliTaq Gold® 
DNA Polymerase, dNTPs, passive reference (ROX) and optimized buffer components 
were subjected to the following experimental run protocol (Table 5) on a 7900HT Fast 
Real-Time PCR System. Reactions were run in triplicates and “non-template” controls 
were included. Melting curve analysis confirmed specific amplification.  
Table 5: Thermal cycling conditions for transcript quantification 
95 °C 3 min Initial denaturation  
95 °C 15 s Denaturation 
45 cycles 
60 °C 1 min Annealing & elongation 
95 °C 30 sec Final denaturation  
55°C 30 sec   
55-95 °C 10 sec Melting curve 80 repeats 
 
Transcriptional stability of five commonly used reference genes Ppib, ubiquitin-
conjugating enzyme E2D 2A Ube2d2, hypoxanthine guanine phosphoribosyl 
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transferase Hprt, beta actin Actb, 18S ribosomal RNA Rn18s), was evaluated in the 
present experimental settings47. Results indicated that Ppib, encoding for cyclophilin B 
protein, was the most stable internal control gene in this study. Hence, data were 
normalized to the reference gene Ppib and analyzed using ∆∆CT-method 46. 
2.6 Immunoblot analysis 
Protein lysates and quantification 
Protein extracts were collected from 3T3-L1 cells 72 hours post Pre-miRTM miRNA 
Precursors/Anti-miRTM miRNA Inhibitors transfection. Cells were scraped in 400 µl pre-
cooled TNT lysis buffer supplemented with Protease (5 µl/ml) and Phosphatase 
Inhibitor Cocktails (10 µl/ml). After double thaw and re-freeze lysates were centrifuged 
at 13,300 rpm for 20 min at 4°C. Protein concentrations of clear supernatants were 
determined using BCA protein assay with bovine serum albumin as standard according 
to manufacturer’s instructions.  
Immunodetection 
Equal amounts of protein from cleared lysates were denatured by incubation at 99°C for 
5 minutes in Laemmli buffer and subsequently separated (10 µg/lane) on a 10 % SDS‐
polyacrylamide gel with the mini‐PROTEAN electrophoresis module assembly. After 
blotting on a PVDF membrane, the membrane was incubated for 1 h at room 
temperatur in 5 % BSA and immunoreacted overnight at 4°C with the respective rabbit 
anti-mouse antibodies against Phospho-p70 S6 Kinase (1:1,000), p70 S6 Kinase 
(1:2,000), Hamartin/Tsc1 (1:1,000), PI3 Kinase p85 (1:1,000), Rsk3 (1:4,000), Akt1 
(1:1,000) and α-Tubulin (1:1,000). Using anti-rabbit IgG HRP-linked antibody (1:2,000) 
proteins were immunodetected by Immun-StarTM HRP Chemiluminescent Kit. In order to 
normalize the observed protein signals to the applied protein amount, membranes were 
stripped with RestoreTM PLUS Western Blot Stripping Buffer for 30 min at 37°C and re-
stained using an anti‐α‐Tubulin antibody (1:2,000). Blots were quantified by ImageJ 
using a digital image analysis approach. 
2.7 Flow cytometry analysis 
For determining transfection efficiencies and cell viability, 3T3-L1 pre-adipocytes were 
transfected with labelled AllStars Negative Control siRNA AF488 (Qiagen). Cells were 
trypsinized and harvested by adding 500 µl growth medium per well. After a washing-
step in PBS, cells were resuspended in flow cytometry buffer (10 % FBS in PBS). Cell 
viability was determined by staining cells with 7-AAD. A working solution of 0.05 µg/ml 
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7-AAD in PBS was prepared and 5 µl were added to a cell suspension of 1 million cells 
following incubation at room temperature for 7 min. A BD FACSCantoTM flow cytometer 
was used to analyze both, cell viability and transfection efficiencies. 10,000 cells were 
measured for each treatment group. Data were collected and analyzed by BD 
FACSDivaTM software.  
2.8 Statistical analysis 
Statistically significant differences of quantitative PCR and reporter assays were 
evaluated using Student’s t-test provided in GraphPad Prism 5.0 (GraphPad Software, 
San Diego, CA, USA). P values of 0.05 or less were considered significant. * indicates 
P ≤ 0.05, ** P ≤ 0.01 and *** P ≤ 0.001. 
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C Results 
1. 3T3-L1 adipocyte model characterization 
Differentiation of 3T3-L1 pre-adipocytes (day 0) into adipocytes (day 6) was evaluated 
by increased levels of the adipocyte marker transcript Pparγ (15-fold, P = 0.073) and 
decreased levels of pre-adipocyte marker transcript Dlk1 (alias Pref-1; 4-fold, P = 0.016, 
Figure 4A). Further increasing deposition of lipid droplets was confirmed by Oil Red O 
staining (Figure 4B).  
 
Figure 4: Inhibitory effects of rapamycin on 3T3-L1 adipogenic differentiation 
(A) Quantification of adipocyte marker Pparγ gene expression and pre-adipocyte 
marker Dlk1 (alias Pref-1) gene expression in untreated (differentiation) and rapamycin-
treated (+ rapamycin) cells undergoing a differentiation protocol for 6 days. Mean values 
± S.E.M. of 2 experiments, each performed in technical triplicates. (B) Phenotypic 
comparison of untreated and rapamycin-treated cells undergoing a differentiation 
protocol for 6 days. Cells were fixed and stained with Oil Red O (200x magnification). 
* P ≤ 0.05, ** P ≤ 0.01 
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The expression of marker genes in rapamycin-treated adipocytes resembled pre-
adipocytes at early stage of differentiation. Additionally, a markedly decreased 
cytoplasmic lipid droplet accumulation compared to mature adipocytes was observed 
(P = 0.012, Figure 4). 
2. In silico target prediction 
A study of our group experimentally identified a set of 22 candidate miRNAs associated 
with both, adipocyte differentiation and mTOR nutrient signaling39. Discovering the 
targets of these miRNAs is essential to unravel their regulatory function. A stringent in 
silico target prediction approach using five different algorithms revealed that 16 
miRNAs, which previously showed rapamycin dependent expression changes in 
differentiation experiments, were also predicted to target mTOR pathway genes (Table 
S 1). Relationship upstream and downstream of the predicted mTOR targets to mTOR 
complex 1 is shown in Figure 5. 
Further molecular pathways being altered by the set of rapamycin-sensitive miRNAs 
were identified using the computational pathway-prediction tool DIANA-miRPath. 
Pathway enrichment analysis revealed that the in silico predicted targets were 
significantly enriched in the mTOR pathway (PPicTar 4-way = 1.95E-03, PTargetScan5 = 5.41E-
03) and other mTOR-related pathways such as insulin signaling (PPicTar 4-way = 7.23E-07, 
PTargetScan5 = 1.90E-03) or MAPK signaling pathway (PPicTar 4-way = 3.01E-09, PTargetScan5 = 
1.53E-09).  
A subset of five miRNA-target pairs, namely miR-183 - Tsc1, miR-378 - Tsc1, miR-103 -
 Pik3r1, miR-107 - Pik3r1 and miR-182 - Pik3r3 were subsequently selected for 
confirmation of direct miRNA-target interaction. Selection criteria were significant 
rapamycin effects on 3T3-L1 adipogenic differentiation, prediction of targets that are 
central genes of the mTOR pathway and/or members of miRNA clusters and families. 
Rapamycin-sensitive expression of these miRNAs was first reproduced and indeed 
confirmed in the current experimental setting (Figure S 2). 
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Figure 5: In silico prediction of miRNA targets within mTOR signaling pathway 
       molecular interaction or activation,         inhibition,        indirect effect. Predicted target 
genes of rapamycin-sensitive miRNAs within mTOR signaling pathway (Table S 1) are 
depicted. mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) are blue-
shaded. Tsc1, Pik3r1 and Pik3r3 genes (encode two different subunits of Pi3k protein) 
were predicted targets of miRNA candidates chosen for further investigation. Rps6kb 
(protein name S6k1) and Vegfa were used for evaluating mTOR output. Rps6ka (protein 
name Rsk) and Akt were investigated as candidate targets upstream Tsc1. 
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3. Functional validation of miRNA-target gene pairs 
To assess binding of the selected miRNAs to the 3’UTR of their target genes, 
luciferase-based reporter assays were performed. HEK-293 cells were co-transfected 
with the respective Pre-miRTM miRNA Precursor molecules and bi-cistronic reporter 
plasmids harboring the 3’UTRs of predicted miRNA target genes. A significantly 
reduced luciferase activity indicated binding of miR-183 and miR-378 to Tsc1 3’UTR 
(P < 0.0001 and P = 0.0013; Figure 6A) and of miR-103 to Pik3r1 3’UTR (P = 0.0022; 
Figure 6B). MiR-107 and miR-182 were not detected to bind to the 3’UTRs of their 
predicted target genes Pik3r1 and Pik3r3 respectively (Figure 6B and C).  
 
Figure 6: MiRNA binding to the 3’UTRs of predicted target genes 
Relative luciferase expression of HEK-293 cells transfected with Pre-miRTM miRNA 
Precursor miR-183, -378, -103, -107 or -182 and a luciferase reporter plasmid 
harbouring the 3’UTRs of predicted target genes (A) Tsc1, (B) Pik3r1 and (C) Pik3r3. 
Mean values ± S.E.M. of 2 independent experiments performed in technical triplicates. 
** P ≤ 0.01, *** P ≤ 0.001 
 
To investigate miRNA-mediated down-regulation of the respective target gene 
expression, 3T3-L1 pre-adipocytes were transfected with Pre-miRTM miRNA Precursor 
molecules. 
For assay establishment 3T3-L1 cells were transfected with AF488 labelled 
oligonucleotides and transfection efficiencies as well as cell viability were measured via 
flow cytometry for various experimental conditions. Survival rates were between 86 % 
 RESULTS 
 
 
31 
and 92 % depending on concentration of transfected siRNA and the selected time point 
(Figure S 3). Flow cytometry analysis showed that percentage of transfected cells 
decreased with time after transfection procedure: Transfection was successful in 71 % 
(P = 0.0015) of cells transfected with 20 pmol of labelled siRNA after 24 hours, 69 % (P 
= 0.0058) after 48 hours and 51 % (P = 0.0026) after 72 hours (Figure 7A, Figure S 4). 
Transfection efficiency increased with rising concentrations of siRNAs: Cells transfected 
with 10 pmol labelled siRNA per well showed a transfection efficiency of 59 % 
(P = 0.0027), with 20 pmol 71 % (P = 0.0014) and with 40 pmol 86 % (P = 0.0001) 
when harvested 24 hours post transfection (Figure 7A, Figure S 5). Flow cytometry 
results were confirmed by rt-PCR. As depicted for miR-378 and miR-183, up-regulation 
of intracellular miRNA levels slightly decreased after 48 and 72 hours and increased 
with rising miRNA-concentrations that were transfected (Figure 7). In subsequent 
experiments cells were transfected with 20 pmol of the respective miRNAs and then 
harvested 72 hours post transfection. The increase in the individual intracellular miRNA 
levels measured via rt-PCR 72 hours post transfection is shown in Figure 7C.  
MiRNA-mediated target mRNA down-regulation was assessed via rt-PCR. Tsc1 
transcript levels were down-regulated significantly in miR-183 (P = 0.0044) and miR-
378 transfected cells (P < 0.0001; Figure 8A). MiR-103 transfection resulted in 
significant down-regulation of Pik3r1 gene expression levels (P < 0.0001; Figure 8B). 
No down-regulation of the predicted target gene Pik3r1 and Pik3r3 expression levels 
was observed in cells transfected with miR-107 and miR-182 (Figure 8B and C). 
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Figure 7: Time course and concentration-dependency of intracellular miRNA 
increase after transfection  
(A) Percentage of transfected 3T3-L1 pre-adipocytes measured by flow cytometry at 
different time points post transfection and in cells transfected with different 
concentrations of labelled siRNA. (B) Time course and concentration dependency of 
miRNA increase after transfection with a candidate Pre-miRTM miRNA quantified by rt-
PCR. (C) Intracellular miRNA levels after transfection with 20 pmol of the respective 
Pre-miRTM miRNA measured via rt-PCR 72 hours post transfection. Mean values ± 
S.E.M. of 2 independent experiments being performed in 6 well replicates. ** P ≤ 0.01, 
*** P ≤ 0.001 
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Figure 8: MiRNA-mediated down-regulation of target transcripts  
Gene expression levels of Tsc1, Pik3r1 and Pik3r3 were quantified using rt-PCR in 3T3-
L1 pre-adipocytes transfected with the respective Pre-miRTM miRNA Precursor or Control 
molecules 72 hours post transfection. Mean values ± S.E.M. of 4 independent 
experiments performed in 6 well replicates. ** P ≤ 0.01, *** P ≤ 0.001 
 
To assess miRNA-mediated effects on target protein levels, immunoblots were 
performed from 3T3-L1 pre-adipocytes transfected with Pre-miRTM miRNA Precursor 
molecules. Tsc1 (alias hamartin) protein levels showed a slight increase in cells 
transfected with miR-183 (36 %, P = 0.30) or miR-378 (40 %, P = 0.50). However, 
Pik3r1 protein levels did not change in miR-103 or miR-107-transfected adipocytes 
(Figure 9).  
4. MiRNA-mediated regulation of mTOR effectors 
mTORC1 has been described to regulate protein synthesis via phosphorylation of S6k1 
and to promote angiogenesis by Hif1a-mediated stimulation of Vegf gene expression48. 
Thus miRNA effects on mTOR signaling were evaluated by measuring phosphorylation 
of S6k1 and by determination of Vegf gene expression levels in 3T3-L1 pre-adipocytes 
transfected with the respective Pre-miRTM miRNA Precursors. Vegf transcript levels 
showed a slight, but significant decrease (P = 0.03) in cells transfected with miR-378. 
There were no significant Vegf transcript level changes in cells transfected with miR-
103, miR-107, miR-182 or miR-183 (Figure 10A). Immunoblot results revealed that 
p-S6k1/S6k1 ratio decreased in cells transfected with miR-183 by 34 % and miR-378 by 
33 %. No changes in p-S6k1/S6k1 ratio were observed in cells transfected with 
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miR-103, miR-107 or miR-182 (Figure 10B and C). Both, altered Tsc1 protein levels 
and S6k1 phosphorylation as well as miR-378-mediated changes in Vegf gene 
expression suggest an attenuating effect of the miRNAs miR-183 and miR-378 on 
mTOR signaling.  
 
Figure 9: MiRNA-mediated effects on target protein levels 
(A) Immunoblots of Pik3r1 protein in 3T3-L1 cells transfected with Pre-miRTM miRNA 
Precursor miR-103 and -107 and Tsc1 protein levels in cells transfected with miR-183 
and-378 72 hours post transfection. α-tubulin was used as loading control. (B) 
Densitometric analysis of immunoblots from 2 independent experiments, each 
presented as relative ratio of the respective protein levels to α-tubulin. The dotted red 
line corresponds to control levels normalized to 1.0. 
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Figure 10: miRNA-mediated regulation of mTOR effectors 
3 days after transfection of 3T3-L1 pre-adipocytes with the respective Pre-miRTM miRNA 
Precursor and control molecules. (A) Vegf transcript levels were quantified using rt-
PCR. Mean values ± S.E.M. of 5 independent experiments each performed in 6 pooled 
replicates and measured in technical triplicates. (B) P-S6K1 and S6K1 levels were 
quantified using immunoblotting. Densitometric analysis of immunoblots each presented 
as relative ratio of the respective protein levels to α-tubulin compared to control cells. 
Mean values ± S.E.M. of 2 independent experiments. The dotted red line corresponds 
to control levels set to 1.0. (C) Immunoblots of p-S6K1 and S6K1 proteins. α-tubulin 
was used as loading control. Samples of rapamycin-mediated mTOR inhibition were 
included as positive control. A representative experiment is shown. * P ≤ 0.05 
 
5. MiRNA-mediated effects on adipocyte differentiation 
To investigate putative effects of the candidate miRNAs during adipocyte differentiation, 
3T3-L1 pre-adipocytes were transfected with the respective Pre-miRTM miRNA 
Precursors or Anti-miRTM miRNA Inhibitors. 48 hours post transfection induction of 
differentiation was initiated (day 0). Our primary hypothesis was that miR-183 and miR-
378 are down-regulating Tsc1 and thereby promote mTOR signaling. Therefore cells 
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were transfected with Anti-miRTM miRNA Inhibitors of miR-183 and miR-378 aiming for 
inhibition of adipogenesis. Intracellular miRNA levels at day 0, day 3 and day 6 of 
differentiation were assessed by rt-PCR (Figure 11A). MiR-183 and miR-378 levels 
were strongly down-regulated by 63 % (P = 0.0001) and by 52 % (P = 0.031) at day 0 of 
differentiation. Intracellular levels of miR-103, miR-107 and miR-182 showed a highly 
significant increase in cells transfected with the respective Pre-miRTM miRNA 
Precursors (Figure 11B) that persisted to day 6 post induction of differentiation. 
 
Figure 11: Time-course of miRNA levels during 3T3-L1 adipogenic differentiation 
after transfection with miRNA inhibitors or precursors 
MiRNA levels were quantified using rt-PCR at day 0, day 3 and day 6 of 3T3-L1 
differentiation. (A) miR-183 and miR-378 levels in cells transfected with the respective 
Anti-miRTM miRNA Inhibitor molecules at day -2. (B) miR-103, miR-107 and miR-182 
levels in cells transfected with the respective Pre-miRTM miRNA Precursor molecules at 
day -2. Mean values ± S.E.M. of 2 independent experiments each measured in 
technical triplicates. The dotted red line corresponds to the respective miRNA levels in 
control cells normalized to 1.0. * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001 
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Next, the relationship between miRNA changes and candidate target transcript levels 
during the time course of differentiation in transfected 3T3-L1 adipocytes were 
analyzed. Tsc1 expression was altered in cells transfected with miR-183 and miR-378. 
However, Pik3r1 and Pik3r3 transcript levels did not show any alterations in cells 
transfected with miR-103, miR-107 or miR-182 (Figure S 6). To uncover miRNA-
mediated effects on adipocyte differentiation adipocyte marker gene Pparγ levels and 
pre-adipocyte marker gene Dlk1 expression levels were determined at day 6 of 
differentiation. Marker transcript levels did not change in cells transfected with miR-103, 
miR-107 or miR-182 (data not shown), whereas Pparγ was up-regulated by 39 % and 
Dlk1 down-regulated by 42 % in cells transfected with anti-miR-183. Similar effects 
(Pparγ up-regulation and Dlk1 down-regulation) were shown for anti-miR-378 
transfected cells. For these, expression level changes were highly significant in all 
experiments (Figure 12).  
 
Figure 12: MiRNA-dependent influence on adipocyte and pre-adipocyte marker 
transcript levels 
Quantification of adipocyte marker Pparγ and pre-adipocyte marker Dlk1 gene 
expression in cells differentiated for 6 days after transfection with the respective Anti-
miRTM miRNA Inhibitors. Data of 2 independent experiments each performed in 
technical triplicates are given. Expression level changes were highly significant in all 
experiments. Mean values ± S.E.M. The dotted red line corresponds to the respective 
mRNA levels in control cells normalized to 1.0. ** P ≤ 0.01, *** P ≤ 0.001 
 
As a major characteristic of mature adipocytes, lipid droplet deposition was evaluated 
using two different lipid-droplet quantification methods. Cells were stained with lipid-
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specific Oil Red O. An absorbance based quantification method determined the Oil Red 
O content in the supernatant of de-stained cells. This approach revealed that the 
miRNAs miR-103, miR-107 and miR-182 decreased lipid droplet deposition, while 
miR-183 and miR-378 had no influence (Figure 13A). Digital image analysis-based 
method additionally evaluated number and size of Oil Red O stained droplets by 
microscopy. This method revealed that the Oil Red O decrease in cells transfected with 
miR-107 or miR-182 was due to a reduced average lipid droplet size whereas the 
number of droplets did not change significantly. Reducing effects of miR-103 were not 
confirmed with this approach, since neither size nor number of lipid droplets reached 
statistical significance. The digital image-based approach further confirmed that anti-
miR-183 and anti-miR-378 transfection did not influence lipid droplet size or numbers 
(Figure 13B and C). 
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Figure 13: MiRNA-dependent decrease in lipid droplet deposition and size during 
adipocyte differentiation 
Oil Red O quantification in 3T3-L1 adipocytes undergoing a differentiation protocol for 6 
days after transfection of the respective Pre-miRTM miRNA Precursorsor Anti-miRTM 
miRNA Inhibitors. (A) Absorbance-based method. 2 independent experiments each 
performed in technical duplicates. Mean values ± S.E.M. (B) Average size and (C) 
number of lipid droplets per field of view quantified by digital image analysis. Data 
represent 2 independent experiments with 10 microscopy pictures each. Mean values ± 
S.E.M. * P ≤ 0.05, *** P ≤ 0.001 
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6. Candidate targets for miRNA effects upstream Tsc1 
Although miR-183 and -378 down-regulated Tsc1 transcript levels, they surprisingly 
raised Tsc1 on protein levels in 3T3-L1 cells. This phenomenon might be explained by 
functionally overruling regulation of targets upstream from Tsc1. According to our target 
prediction results (Table S 1), miR-378 could also target Akt1 and miR-183 Rsk3 
protein (encoded by Rps6ka2 gene). Both proteins are direct inhibitors of the Tsc 
complex (Figure 5) and thus could overrule miR-183 and -378 mediated Tsc down-
regulation. To investigate miR-183 - Rsk3 and miR-378 - Akt1 target pairs, Rps6ka2 
and Akt1 transcript as well as protein levels were determined in cells transfected with 
Pre-miRTM miRNA Precursors miR-183 and miR-378. However, miRNA-mediated down-
regulation was neither observed on target transcript nor protein levels (Figure 14). 
 
 
Figure 14: Effects of miR-183 and miR-378 on their predicted targets Rsk3 and 
Akt1 
Protein and transcript levels were assessed 3 days after transfection of 3T3-L1 pre-
adipocytes with the respective Pre-miRTM miRNA Precursor and Control molecules. (A) 
Rps6ka2 (encoding for Rsk3 protein) and Akt1 transcript levels were quantified using rt-
PCR. Rsk3 and Akt1 protein levels were quantified by immunoblotting. Densitometric 
analysis of immunoblots each presented as relative ratio of the respective protein levels 
to α-tubulin compared to control cells (dotted red line). Mean values ± S.E.M. of 3 
independent experiments. (B) Immunoblots of Rsk3 and Akt1 proteins. α-tubulin was 
used as loading control. A representative experiment is shown. 
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7. Evaluation of miRNA families and clusters on adipocyte differentiation 
Particular attention was paid to the miRNA candidates miR-103 and -107 as well as 
miR-183 and -182, since these miRNAs hold special genetic backgrounds. The 
candidate miRNAs miR-103 and -107 form a miRNA family as their genes are 
paralogues deriving from gene duplication33.  
Firstly, the hypothesis of a miRNA family multiplying the effect of the single miRNA 
family members was investigated. Therefore 3T3-L1 pre-adipocytes were co-
transfected with Pre-miRTM miRNA Precursors miR-103 and miR-107 and lipid droplet 
deposition as well as adipocyte marker gene levels were evaluated during adipocyte 
differentiation. Overall miRNA concentration utilized for transfection was equal to that 
used for cells transfected with a single miRNA, i.e. half of the concentration of each 
miRNA compared to single miRNA transfection was employed. Transfection efficiency 
was assessed by rt-PCR quantification of intracellular miRNA levels revealing very high 
relative increases at day 0 with persistent up-regulation up to day 6 (Figure 15).  
 
Figure 15: MiRNA expression during 3T3-L1 adipogenic differentiation after 
transfection with miRNA family 103/107 at day -2 
MiR-103 and miR-107 levels were quantified using rt-PCR at day 0, day 3 and day 6 of 
3T3-L1 differentiation after co-transfection at day -2. Mean values ± S.E.M. of 2 
independent experiments each measured in technical triplicates. The dotted red line 
corresponds to the respective miRNA levels in control cells normalized to 1.0. 
* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001 
 
To uncover effects of miRNA family 103/107 on adipocyte differentiation, lipid droplet 
deposition as well as adipocyte and pre-adipocyte marker expression levels were 
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determined at day 6 of differentiation. Lipid droplet deposition was evaluated using 
digital image analysis-based Oil Red O quantification. Figure 16 shows that cells 
transfected with both, miR-103 and miR-107 gained significantly less lipid droplets 
during differentiation than cells transfected with each miRNA separately. Total area 
fraction of lipid droplets was reduced by 25 % (P = 0.0012) after family 103/107 
transfection, whereas it slightly decreased by 11 % in cells transfected with miR-107 
only and not altered after transfection of miR-103 only. The alterations in droplet area of 
cells transfected with miRNA family 103/107 were due to a significant decrease in lipid 
droplet number by 12 % (P = 0.027). In contrast, miR-107 alone decreased lipid 
droplets by reducing their size by 20 % (P = 0.024; Figure 16). Additionally adipocyte 
marker Pparγ as well as pre-adipocyte marker Dlk1 transcript levels were determined 
via rt-PCR. Gene expression of both markers were unaffected by transfection of miRNA 
family 103/107 (data not shown). 
 
 
Figure 16: Effect of miRNA family miR-103/107 on lipid droplet deposition  
Oil Red O quantification of 3T3-L1 cells undergoing the adipogenic differentiation 
protocol for 6 days after transfection of the respective Pre-miRTM miRNA Precursors. 
Area fraction, average size and number of lipid droplets per visual sight quantified by 
digital image analysis. 2 independent experiments with 10 microscopy pictures each 
were analyzed. Mean values ± S.E.M. * P ≤ 0.05, ** P ≤ 0.01 
 
The genes of the candidate miRNAs miR-182 and -183 are clustered together with miR-
96 gene, meaning that their chromosomal distance is less than 10,000 nucleotides28, 32. 
The hypothesis of miRNA cluster 183/96/182 multiplying the effect of the single miRNA 
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cluster members was investigated. Therefore 3T3-L1 pre-adipocytes were co-
transfected with Pre-miRTM miRNA Precursors cluster members miR-182, miR-96 and 
miR-183. Overall concentration of miRNAs transfected was equal to that of cells 
transfected with a single miRNA (each one third of the concentration of single miRNA 
experiments). Transfection efficiency was assessed by quantification of intracellular 
miRNA levels (Figure 17).  
After co-transfection with miR-183/96/182 cluster members, adipocyte and pre-
adipocyte marker transcript levels (Figure 18) as well as lipid droplet deposition were 
determined. Adipocyte marker gene Pparγ expression decreased by 18 %, whereas it 
did not change significantly in cells transfected with miR-182 or miR-96 separately. Pre-
adipocyte marker Dlk1 expression did not change in cells transfected with miRNA 
cluster 183/96/182. Likewise, lipid droplet deposition was not altered in cells transfected 
with miRNA cluster 183/96/182 (data not shown). 
 
Figure 17: MiRNA expression during 3T3-L1 adipogenic differentiation after 
transfection with miRNA cluster 183/96/182 at day -2 
MiR-183, miR-182 and miR-96 levels were quantified using rt-PCR at day 0, day 3 and 
day 6 of 3T3-L1 differentiation after co-transfection at day -2. Mean values ± S.E.M. of 2 
independent experiments each measured in technical triplicates. The dotted red line 
corresponds to the respective miRNA levels in control cells normalized to 1.0. 
* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001 
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Figure 18: Effect of miRNA cluster 183/96/182 on adipocyte differentiation marker 
Rt-PCR mediated quantification of adipocyte marker Pparγ and pre-adipocyte marker 
Dlk1 gene expression in cells differentiated for 6 days after transfection with the 
respective Pre-miRTM miRNA Precursors. 2 independent experiments each performed in 
technical triplicates. The dotted red line corresponds to the respective mRNA levels in 
control cells normalized to 1.0. Mean values ± S.E.M. * P ≤ 0.05 
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D Discussion 
MiRNAs have been reported to play a regulatory role in adipocyte differentiation, 
obesity and its associated pathologies34, 40, 49. Among various nutrient signaling 
pathways regulating cell growth and cell differentiation towards maintenance of whole-
body metabolic homeostasis, the mTOR pathway is an evolutionary conserved and 
well-studied regulator of adipogenesis8. The identification of miRNAs that influence 
adipocyte differentiation via mTOR nutrient signaling may provide a new approach for 
treatment or early diagnosis of chronic metabolic diseases. Four miRNAs have 
previously been implicated in mTOR nutrient signaling in the context of cancer and 
dermal wound healing35-38 but the pattern of miRNA regulation involved in mTOR 
signaling during adipocyte differentiation has not yet been elucidated. Thus we 
specifically aimed at identifying miRNAs that are influencing adipogenesis via targets in 
the mTOR pathway. 
1. Rapamycin alters expression of miRNAs 
In previous work of our group a set of mTOR associated miRNAs was already identified 
by differentiating adipocytes in the presence and absence of mTOR inhibitor rapamycin. 
40 miRNAs showed differential regulation during adipocyte differentiation in the 
absence of any pharmacological alteration of the mTOR pathway. These results were 
consistent with earlier published studies reporting more than 30 of these differentially 
regulated miRNAs, that appear to be involved in regulating fat cell differentiation in 
adipocyte cell lines derived from humans and mice (reviewed in34, 40, 50). Beyond this 
prior knowledge, our study additionally revealed differential regulation of miR-34a, -96, -
106b, -148b, -678, -690 and -214*, all of these not yet documented in the context of fat 
cell differentiation. Some of these miRNAs have been implicated in insulin signaling or 
glucose metabolism, such as miR-96 or miR-69051, 52 or in cell cycle regulation, such as 
miR-96, miR-106b or miR-34a53-58. MiRNAs, whose expression is significantly altered 
during differentiation, must be expected to arise as a consequence of regulatory events 
occurring in numerous pathways that govern adipogenesis59. To identify differentiation-
associated miRNAs which are involved in mTOR signaling, one of the key nutrient 
sensing pathways, 3T3-L1 adipocytes were chronically treated with the mTOR-inhibitor 
rapamycin during differentiation procedure. Firstly, we confirmed the inhibitory effect of 
rapamycin on adipocyte differentiation as evidenced by quantification of marker 
transcripts and decreased deposition of lipid droplets15, 60, 61. Thereafter, miRNA profiles 
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from 3T3-L1 cells undergoing an adipogenic differentiation protocol over eight days in 
the presence and in the absence of rapamycin were compared. Almost half of the 
miRNAs differentially regulated during adipogenesis were also sensitive to rapamycin-
treatment. Chronic mTOR inhibition resulted in attenuation of regulation of these 
differentiation-associated miRNAs and corroborates the central role of mTOR in nutrient 
driven adipocyte differentiation. Four additional miRNAs were identified as ‘rapamycin-
sensitive’, though showing no differential regulation during adipogenesis. These 
miRNAs may mediate differentiation-independent effects of mTOR signaling.  
2. Selected miRNAs target predicted genes 
2.1  In silico target prediction 
The specific aim of this study was to discover the targets of mTOR associated miRNAs 
to unravel their regulatory function within mTOR signaling. To identify presumptive 
direct miRNA-target pairs within the mTOR pathway, our set of ‘rapamycin-sensitive’ 
miRNAs was subjected to a stringent in silico target prediction. This is an important step 
for high-throughput pre-selection of putative targets, to narrow down the number of 
miRNA-target pairs which have to be functionally confirmed in the next steps.  
Computational miRNA target prediction still remains challenging as the binding of 
miRNAs to their respective target genes does not require full complementarity and the 
binding patterns are not yet fully understood62. Various prediction tools have been 
developed based firstly on the complementarity between the 5’ seed region of the 
miRNA and the 3’UTR of the target gene, secondly on thermodynamic stability of 
miRNA-target alignments and thirdly on miRNA:mRNA duplex conservation between 
species63. Since each prediction tool applies distinct algorithms, they predict differing 
sets of targets. Furthermore, it has already been reported that target predictions may 
generate an estimated rate of 31 % false positive targets64. To overcome these 
limitations we aimed to increase the prediction specificity by combining five different 
prediction algorithms. The set of ‘rapamycin-sensitive’ miRNAs was subjected to PITA, 
miRanda, targetScanS, pictar and targetspy algorithms and only those miRNA-target 
pairs with a consensus target prediction of at least 2 algorithms were considered as 
presumptive candidates. Although this stringent approach may lead to higher specificity 
(percentage of correctly predicted among overall predicted ones), it may result in 
decreased sensitivity (percentage of correctly predicted targets out of total correct 
ones)62. This may lead to the loss of some miRNA-target pairs in our approach.  
 DISCUSSION 
 
 
47 
However, subjecting the ‘rapamycin-sensitive’ miRNAs to our stringent prediction 
approach revealed that more than two thirds of these miRNAs were indeed predicted to 
target genes of the mTOR pathway. This finding indirectly confirmed the utility of 
rapamycin in the experimental discovery approach. For functional confirmation we 
selected five miRNA-target pairs according to the in silico prediction results: miR-183-
Tsc1, miR-378-Tsc1, miR-103-Pik3r1, miR-107-Pik3r1 and miR-182-Pik3r3. All of these 
miRNAs already showed strong rapamycin effects in the differentiation experiments and 
were predicted to target central genes of the mTOR pathway. 
To validate the set of ‘rapamycin-sensitive’ miRNAs in reverse, the computational 
pathway-prediction tool DIANA-miRPath was used. This tool is focused on the 
identification of miRNA targeted pathways and thus provides an insight into functional 
characterization of the predicted miRNA target genes65. With this method, we 
investigated the molecular pathways which may be altered by the set of rapamycin-
sensitive miRNAs. Here, mTOR pathway targets were found to be significantly enriched 
in the set of predicted rapamycin-sensitive miRNA targets. These results are in line with 
the findings of in silico target prediction and they additionally confirm our experimental 
discovery approach.  
2.2  Functional confirmation by luciferase-based reporter assays 
In a first step, functional confirmation of miRNA targets was investigated by luciferase-
based reporter assays, a routinely used and efficient assay for the validation of 
individual miRNA-mRNA interactions. For this purpose, HEK-293 cells were co-
transfected with the respective miRNA molecules and reporter plasmids harboring the 
3’UTRs of the respective, predicted miRNA target genes.  
Reporter assays revealed that miR-183 and miR-378 bind to the 3’UTR of their 
predicted target gene Tsc1 and that miR-103 binds to its target gene Pik3r1. However, 
physical interaction of miR-107 with Pik3r1 3’UTR and miR-182 with Pik3r3 3’UTR was 
not confirmed. Herewith we show that miR-183, miR-378 and miR-103 may target 
components of mTOR signaling, which needs to be further confirmed in a second, 
functional approach. The rate of interactions we detected is concordant with Lewis et al. 
reporting an estimated false positive in silico prediction rate as high as one third64. 
Nevertheless, all five miRNA-mRNA target pairs were subjected to further functional 
confirmation assays.  
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2.3 Functional confirmation by transfection experiments 
As a second approach for functional confirmation of the miRNA-target pairs, miRNA-
mediated effects on target gene expression were investigated. Therefore adipocytes 
were transfected with the respective miRNAs and target transcript levels were 
quantified.  
To identify ideal concentrations of miRNA that are transfected and appropriate time 
points for cell harvest, some pre-experiments were performed. Transfection efficiencies 
were evaluated by determination of intracellular miRNA levels via rt-PCR and by 
measuring the percentage of transfected cells via flow cytometry. On the one hand the 
flow cytometry-based approach for establishment of transfection conditions is very fast, 
simple in workflow and enables simultaneous determination of cell viability. On the other 
hand this approach investigates conditions in cells transfected with a labelled control 
siRNA and thus is not specific for individual miRNAs. We thus additionally confirmed 
flow cytometry results via a rt-PCR-based approach. Although rt-PCR is more time-
consuming, this approach enables to investigate fold changes of individual miRNAs and 
thus is essential to validate successful transfection in the experiment.  
For both approaches cells were transfected with various concentrations of 
siRNA/miRNA and harvested at various time points. Flow cytometry results of siRNA 
transfected cells as well as rt-PCR results of cells transfected with the respective 
candidate miRNAs were concordant: Transfection efficiency increased with increasing 
concentrations of transfected miRNA molecules and decreased with time. Since a 
longer time span post transfection allows the cell to process miRNA-mediated effects on 
target transcripts and to retain a high number of viable cells, transfection was carried 
out with 20 pmol of the respective miRNAs and cells were harvested 72 hours post 
transfection for further validation experiments. These pre-experiments showed that the 
flow-cytometry based approach is suitable for fast screening of many different 
experimental conditions of transfection, whereas rt-PCR based validation of successful 
transfection is mandatory to control intracellular levels of the individual miRNAs. We 
thus validated successful transfection in our experiments via quantification of the 
respective intracellular miRNA levels and noticed that the relative increase is miRNA 
dependent. This may be due to individual endogenous expression levels of the 
respective miRNAs. MiR-107 for example showed lower endogenous expression 
(CT = 34.5±0.3) and consequently higher fold changes (~7,400), whereas miR-182 is 
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higher expressed under physiological conditions (CT = 28.6±0.4) and increases 923-fold 
after transfection.  
With this knowledge, miRNA-mediated effects on target transcript levels were 
investigated for further functional confirmation in transfection experiments. For this 
purpose, target gene expression changes were quantified in adipocytes transfected with 
the respective miRNAs. These experiments revealed that miR-183 and miR-378 down-
regulated Tsc1 gene expression and miR-103 down-regulated Pik3r1 expression, 
whereas miR-107 did not change its predicted target transcript Pik3r1 levels and miR-
182 did not change Pik3r3 transcript levels. These results resemble those of luciferase-
based reporter assays. However, a limitation of these experiments is that miRNA 
transfection results in supra-physiological miRNA levels, which may lead to multiple 
artifacts66. Another drawback for validation of miRNA-target pairs with this method is 
that transcriptomes highly depend on cell type, culture conditions etc.62. That is why our 
experiments were performed using adipocytes in an environment of nutrient 
satisfaction, where mTOR signaling should be activated and hence even lower gene 
expression changes are detectable. Additionally, the miRNA-transfection approach can 
not distinguish direct from indirect targets, a disadvantage we overcome by combination 
with reporter assay results, which are indicating direct miRNA effects62. To eliminate 
effects on cells and gene expression mediated by the transfection procedure, we used 
cells transfected with a control miRNA for normalization. These findings, together with 
the results from luciferase-based reporter assays indicate that miR-183, miR-378 and 
miR-103 may target genes within mTOR signaling, which needs to be further confirmed 
on protein level. 
2.4  Functional confirmation on protein level 
Thus, in the next step candidate miRNA-mediated effects on mTOR targets were 
investigated on protein level. Therefore protein level changes were quantified in 
adipocytes transfected with the respective miRNAs.  
Immunoblotting of miR-103 and miR-107-transfected cells revealed that there were no 
detectable changes in Pik3r1 protein levels. The result for miR-107-transfected cells is 
not surprising as miR-107 did neither change Pik3r1 transcript levels nor luciferase 
activity in reporter assays. In contrast, Pik3r1 protein levels remained unaffected in 
miR-103 transfected cells, although miR-103 has been shown to down-regulate Pik3r1 
gene expression in the above experiments. Although immunoblotting is considered as a 
rather qualitative method to detect a protein in a complex sample, improvements in 
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terms of sensitivity and stability of the detection signal allow its use for relative 
quantification. However, due to limitations resulting from a narrow detection range, 
difficulties to determine linear quantification ranges for each protein and variance 
arising from sample loading, protein transfer and signal imaging, the detection of small 
alterations in protein levels via immunoblotting still remains challenging67, 68. Thus either 
the miR-103-mediated effect on its target gene is not powerful enough to be functionally 
relevant on protein level or the alteration in protein expression is not strong enough to 
be detected by semi-quantitative immunoblotting. Moreover, as described for the 
transcriptome, also the proteome is highly dependent on cell physiology, so that 
miRNA-independent regulation mechanisms may overrule miRNA-mediated protein 
down-regulation62. For elimination of putative cell physiological effects, all cells were 
cultured under equal conditions of an environment of nutrient satisfaction, where mTOR 
signaling is activated and hence gene expression changes detectable, as for 
transfection experiments. A putative effect of miR-103 as well as of miR-107 on mTOR 
signaling (possibly via so far uninvestigated targets) was examined in subsequent 
experiments. 
MiR-183 and miR-378 transfection resulted in a slight Tsc1 protein up-regulation, even 
though both miRNAs have been shown to decrease Tsc1 on transcript level. The 
unexpected phenomenon of inversely correlated Tsc1 transcript and protein levels 
could be due to functionally overruling regulation of up-stream targets resulting in de-
regulated protein levels in the downstream signaling cascade. To further investigate this 
hypothesis, we returned to in silico target prediction. MiR-183 was additionally predicted 
to target Rps6ka2 gene encoding Rsk3 protein and miR-378 was predicted to target 
Akt1, both up-stream inhibitors of the Tsc complex. Overruling down-regulation of up-
stream inhibitors could explain the observed Tsc1 protein increase. Thus we 
determined Rsk3 and Akt1 transcript and protein levels in 3T3-L1 cells transfected with 
miR-183 and miR-378 respectively. However, results showed that neither miR-183 nor 
miR-378 down-regulated the predicted targets. 
Table 6 provides an overview of miRNA-mediated effects on predicted targets, mTOR 
signaling and adipocyte differentiation.  
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Table 6: Summary of miRNA effects on predicted targets, mTOR signaling and 
adipocyte differentiation  
Effects which would lead to attenuation of adipocyte differentiation are highlighted in 
green, effects which would drive adipocyte differentiation are highlighted in red. *, ** and 
*** indicate significant changes; ND: protein levels were not determined. 
 miR-183 miR-378 miR-103 miR-107 miR-182 
binding to 
target 3’UTR *** ** **   
regulating 
target gene ** *** ***   
regulating 
target protein     ND  
influencing 
mTOR output      
influencing 
differentiation ** 
1)
 *** 
1)
  *
2)
 *** 
2)
 
1) alterations in adipocyte and pre-adipocyte marker genes 2) alterations in lipid droplet deposition 
 
3. Effects of selected miRNAs on mTOR-signaling  
To further investigate the candidate miRNA effects on mTOR signaling, adipocytes 
were transfected with the respective miRNA molecules. Since mTORC1 promotes 
angiogenesis via Vegf gene expression stimulation and regulates protein synthesis via 
S6k1 phosphorylation, miRNA effects on mTOR signaling were evaluated by 
determination of p-S6k1/S6k1 ratio and Vegf transcript levels.  
Since miR-182, miR-103 and miR-107 were not confirmed to influence their target gene 
and/or protein levels in the previously described experiments, it was not surprising that 
they did not influence mTOR signaling during differentiation (Table 6). This would lead 
to the conclusion that these miRNAs do not influence mTOR signaling up-stream the 
investigated effectors. But since these miRNAs showed rapamycin-sensitive expression 
changes, miR-103 and miR-107 might still target Eif4b, another predicted gene down-
stream of mTOR complex 1 and the investigated effectors. Mir-182 might be involved in 
autophagy, a pathway which can be activated by mTOR signaling via the predicted 
target and mTOR effector Ulk.  
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In contrast to miR-103, -107 and -182, transfection of miR-183 and miR-378 decreased 
S6k1 phosphorylation though not reaching statistical significance. This result is in 
concordance with the previous experiment, in which miR-183 and miR-378 transfection 
resulted in increased mTOR inhibitor Tsc1 protein levels (Table 6) and may point to an 
effect of these miRNAs on general protein synthesis. MiR-378 additionally decreased 
Vegf transcript levels significantly and thus this miRNA might affect angiogenesis as 
well as general protein synthesis. These findings indicate that miR-183 and miR-378 
indeed influence mTOR nutrient signaling and thereby expand the list of the four 
previously experimentally confirmed miRNAs that target the mTOR pathway in other 
biological settings, namely miR-99a and -b, miR-100 and miR-199a-3p35-38.  
4.  Effects of selected miRNAs on adipocyte differentiation 
To investigate the candidate miRNA effects on adipocyte differentiation, adipocytes 
were transfected with the respective miRNAs/anti-miRNAs and subsequently 
differentiation was initiated. After 6 days of differentiation lipid droplet deposition as well 
as adipocyte marker Pparγ and pre-adipocyte marker Dlk1 expression levels were 
quantified. Ppary is a transcription factor leading to fundamental changes in gene 
expression resulting in the stimulation of proteins critical for adipogenesis. Since Pparγ 
expression is maintained throughout the differentiation process, Pparγ transcript levels 
are routinely used as adipocyte marker. Although the mechanisms, by which Dlk1 (alias 
pre-adipocyte factor-1) influences adipocyte differentiation are not as intensively studied 
as those of Pparγ, it is a generally accepted pre-adipocyte marker.  
Lipid droplets were visualized via Oil Red O staining and then quantified applying two 
different methods. The shorter approach for quantification was absorbance 
measurement of the supernatant from de-stained cells. Since the results are strongly 
depending on equal confluence of cells between wells, we normalized the values to cell 
numbers. In this study Oil Red O absorbance values were normalized to this parameter 
via Cellscreen microscopy. There are only few other techniques available to gain more 
information about lipid droplets, such as amount and size. Our approach for 
determination of lipid droplet size and numbers was to take digital microscopy pictures 
of Oil Red O stained cells, which are subsequently analyzed by a digital image analysis 
software44. Since microscopy pictures are taken from areas with complete cell 
coverage, it is not necessary to determine cell numbers per well. One advantage of this 
method is that only a standard light microscope and the freely available software tool 
ImageJ is needed. ImageJ enables automating of the commands and thus reduces time 
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requirements. Further, because of the simplicity of this software tool, the approach is 
applicable for users without previous imaging or programming expertise. The most 
important advantage is the possibility to evaluate individual lipid droplet size and 
numbers, though a limiting factor can occur by incomplete droplet separation of highly 
dense packed droplet clusters. In our study, however, experiments revealed 
consistency between the microscopy-based and the absorbance-based method.  
Digital microscopy picture analysis showed a significant decrease of lipid droplet 
deposition in cells transfected with miR-107 and miR-182. The absorbance-based 
method accordingly showed declining absorbance values normalized to cell coverage. 
Additionally, the microscopy-based method revealed that the decrease in lipid droplet 
formation is due to droplet size reduction. Thus these miRNAs seem to influence 
adipocyte differentiation by affecting lipid droplet size (Table 6). While the molecular 
mechanism are not yet fully understood, it is already known that S6k1, a down-stream 
effector of mTOR, controls lipid metabolism69. Although miR-107 and miR-182 
expression appeared to be highly sensitive to rapamycin treatment in our study, these 
miRNAs influenced lipid droplet formation S6k1 phosphorylation independently in our 
study. But there are S6k1-independent mechanisms of mTOR mediated de novo 
lipogenesis already known. Firstly, mTOR complex 1 can stimulate lipogenic genes by 
induction of the key transcription factor Pparγ via 4Ebp169. However, since the 
adipocyte marker gene Pparγ expression remained unchanged in cells which were 
differentiated after miR-107 and miR-182 transfection, these miRNAs may not influence 
lipid droplet deposition via this mTOR-4Ebp1-Pparγ axis. A second mechanism linking 
mTOR to lipid droplet formation is mTOR mediated inhibition of Atgl transcription 
(adipose triglyceride lipase), an enzyme which controls lipid homeostasis9. Thirdly it has 
been reported that mTOR complex 1 can promote de novo lipogenesis via Srebp-1 
activation, a transcription factor controlling gene expression of lipogenic genes69. Thus 
miR-182 and miR-107 may influence lipid droplet formation via targets down-stream of 
mTOR being part of this Atgl or Srebp-1 mediated mechanisms. Thus these miRNAs 
could show rapamycin-sensitivity on the one hand and pS6k1 and Pparγ independence 
on the other hand. Concordant to our results, miR-107 and miR-182 have been 
implicated in adipocyte differentiation in other studies34, 40. Meng et al. showed that 
under hypoxic conditions miR-107 suppressed endothelial progenitor cell differentiation 
via Hif1ß, whereas in our study miR-107 did not influence the mTOR-Hif1-Vegf 
angiogenesis pathway under physiological oxygen conditions70. These findings 
demonstrate an example for a miRNA effect dependent on the respective physiological 
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conditions. To the best of our knowledge the targets by which miR-182 influences 
adipocyte differentiation have not yet been discovered.  
Adipocytes transfected with miR-103 did not show any differences in absorbance-based 
or in microscopy-based Oil Red O quantification. Further, the expression of pre-
adipocyte and adipocyte marker genes was not altered by miR-103 transfection (Table 
6). Thus miR-103 did neither influence the mTOR effectors investigated nor 
differentiation markers or lipid droplet deposition in our study. These findings were 
consistent with an earlier study reporting normal triglyceride levels in differentiated 3T3-
L1 adipocytes ectopically expressing miR-103, although the same study reported a 
miR-103-mediated increase in triglycerides in the early stage of 3T3-L1 differentiation70. 
Reported in vivo studies are inconsistent: in mice mir-103 was found to be down-
regulated in mature adipocytes, whereas it was up-regulated in human adipose tissue34. 
Thus miR-103 may accelerate adipocyte differentiation while not affecting the final state 
of the differentiated cell. 
Lipid droplet deposition remained unchanged in differentiated cells transfected with anti-
miR-183 or anti-miR-378 in our study. However, both miRNAs showed an attenuating 
effect on adipocyte differentiation as anti-miR-183 and anti-miR-378 treatments led to 
increased adipocyte marker and decreased pre-adipocyte marker gene expression in 
our study (Table 6). Triacylglycerol molecules are neutral lipids synthesized by cells in 
times of nutrition excess and are stored in lipid droplets71. Thus synthesis of 
triacylglycerol may correlate with lipid droplet formation. In concordance to our results, 
another study inhibiting miR-378 via antagomirs discovered no significant changes in 
triacylglycerol levels or adipocyte morphology in the late stages of differentiation. 
However, the same study reported increased triacylglycerol levels and accelerated lipid 
droplet growth in early stages of differentiation after overexpression of miR-378 and 
miR-378*72. Although it was not possible to distinguish whether the effects on 
lipogenesis were due to miR-378 or miR-378* in that study, the authors stated that 
miR-378 together with miR-378* stimulate adipogenesis in the early stages of 
differentiation. Our study describes an attenuating effect of miR-378 in the late stages 
of differentiation: the opposite effect in the early stages of differentiation may either be 
caused by miR-378*, which is not investigated in our study, and/or miR-378 might be 
involved in a negative feedback regulatory mechanism in the late stages of 
differentiation. Targeting genes within this feedback mechanism may overrule less 
important targets, such as previously described for Tsc1 on protein level, thereby 
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leading to inversely correlated Tsc1 transcript and protein levels. Our results showed 
firstly that miR-378 was strongly up-regulated in the late phase of adipocyte 
differentiation (Figure S 7), secondly that miR-378 indirectly increased mTOR inhibitor 
Tsc1 and thirdly attenuated mTOR effectors. Taken together these findings are 
consistent with our hypothesis of miR-378 being involved in a negative feedback 
regulation of mTOR signaling. We propose that miR-378 might be involved in the well 
characterized suppression of Pi3k by mTORC1 activated S6k173, 74. In this process 
prolonged growth factor-mediated mTOR activation and hence S6k1 phosphorylation 
strongly down-regulate insulin signaling via the Pi3k-Tsc-mTOR axis. In vivo this 
mechanism of uncoupling Pi3k may be required to block further activation as soon as 
sufficient growth has been reached73.  
In our study miR-183 did not influence lipid droplet deposition, but revealed an 
attenuating effect on adipocyte differentiation as evidenced by its influence on 
adipocyte/pre-adipocyte marker gene expression at late stages of differentiation. These 
results are in line with the attenuating effect of this miRNA on mTOR effector S6k1 and 
the increasing effect on mTOR inhibitor Tsc1. Chen et al. could not detect a miR-183 
dependent influence on marker gene expression changes in the late stages of 
differentiation, however, in the early stages of differentiation, they report a miR-183 
dependent increase in marker gene expression and lipid droplet deposition75. The effect 
of miR-183 on adipocyte differentiation seems to be opposed in early and late stages of 
differentiation as already described for miR-378. Besides miR-378, miR-183 was also 
strongly up-regulated in the late phase of adipocyte differentiation (Figure S 7) and 
affected genes of the Tsc-mTOR-S6k1 axis in an adipocyte differentiation attenuating 
manner. Thus miR-183 may also be part of a negative feedback mechanism, such as 
the S6k1 phosphorylation activated Pi3k suppression73, 74. Such mechanism would lead 
to overruling effects on previously described miR-183 target Tsc1 on protein level as 
already mentioned for miR-378.  
The better understanding of the involvement of miRNAs in adipocyte differentiation may 
give important inputs about the regulation of mammalian adipogenesis and might even 
provide an approach for therapeutic options. For example, recent studies detected 
miRNAs as biomarkers in several chronic diseases like cardiovascular disease, cancer 
and type 2 diabetes76-78. Thus, in the future, miRNAs might also be used for clinical 
diagnosis and treatment monitoring of chronic diseases34.  
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5. MiRNA cluster 183/96/182 and miRNA family 103/107 
Clustered miRNAs derive from a common multi-cistronic pri-miRNA and thus are 
influenced by similar regulation mechanisms28, 32. That is why clustered miRNAs are 
thought to be functionally related and, like miRNA families, of particular biological 
relevance. MiRNA families derived from gene duplication thereby often share seed 
sequences33. In contrast to miRNA clusters, miRNA families may act redundantly by 
targeting similar gene sets, whereas clustered miRNAs may act coordinately by 
targeting different genes within one pathway51. We thus investigated potential additional 
effects of clustered miRNAs or miRNA families compared to its individual miRNA 
members on adipocyte differentiation. For this purpose, 3T3-L1 pre-adipocytes were 
transfected with either miRNA cluster 183/96/182 or miRNA family 103/107 and 
subsequently subjected to differentiation.  
We found that miRNA cluster 183/96/182 influences adipocyte differentiation by down-
regulating adipocyte marker Pparγ gene expression, while miR-182 and miR-96 alone 
did not affect marker gene levels. However, miR-183 alone had a strong effect on Pparγ 
and Dlk1 gene expression in the above experiments. The effects of the cluster may thus 
mainly be mediated by miR-183 in our study. However, cluster 183/96/182 has 
previously been described to play an important regulatory role by targeting several 
signaling pathways, including insulin signaling51. Since the expression of this cluster 
was characterized by high rapamycin-sensitivity, our study expands this knowledge by 
adding mTOR signaling as presumptive function of this cluster.  
MiRNA family 103/107 influenced adipocyte differentiation by decreasing lipid droplet 
numbers, whereas miR-107 alone reduced lipid droplet size and miR-103 alone did not 
affect lipid droplet deposition at all. Although miR-103 and miR-107 reside on different 
chromosomes they are located within introns of a set of genes encoding for enzymes 
involved in fatty acid, amino acid, cholesterol, pyruvate or glucose metabolism79. Wilfred 
et al. reported that bioinformatics predict target genes of these miRNAs in lipid 
metabolism, which could result in decreasing fatty acid synthesis and uptake. Until now, 
however, experimental data for this hypothesis was lacking79. Our study may provide 
the first experimental evidence for the involvement of this miRNA family in lipid 
metabolism by decreasing lipid droplet deposition. This effect is likely mTOR-signaling 
associated due to the miRNAs’ rapamycin-sensitive expression changes during 
adipocyte differentiation. We conclude from these findings, that miRNA families may 
 DISCUSSION 
 
 
57 
exhibit regulatory effects on adipogenesis additionally to those of the respective single 
miRNAs.  
Our findings support a recently suggested concept of miRNA regulation: Entire 
networks of multiple miRNAs targeting multiple genes should be considered, instead of 
one miRNA-one target gene pairs31, 66. On the one hand one gene may be targeted by 
multiple miRNAs, on the other hand one miRNA may target multiple genes even within 
one pathway, thereby reaching biological importance, despite weak effects of individual 
miRNA-target pairs. A more complete understanding of the complex regulatory 
networks of miRNAs and their targets still remains a challenge in the miRNA field that 
needs to be overcome31, 66. 
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E Summary 
Obesity is defined as abnormal or excessive fat accumulation which may have adverse 
effects on health. On adipose tissue level the development of obesity is dependent on 
the coordinated interplay of adipocyte hypertrophy, pre-adipocyte proliferation and 
differentiation of pre-adipocytes into mature fat cells. The mechanistic target of 
rapamycin (mTOR) signaling is an evolutionary conserved and well-studied nutrient-
signaling pathway adapting cell differentiation to nutrient availability. In addition, 
miRNAs appear to play a crucial regulatory role as more than 40 miRNAs have 
previously been reported as being associated with adipocyte differentiation. In this 
study, we specifically aimed at identifying distinct miRNAs that are governing nutrient-
driven adipogenesis via the mTOR pathway. 
Taken together, we identified a subset of 16 miRNAs showing both responsiveness to 
rapamycin and prediction as targets within the mTOR pathway. We confirmed target 
3’UTR binding and target transcript regulation of the predicted miRNA-target pairs 
miR-183 - Tsc1, miR-378 - Tsc1 and miR-103 - Pik3r1. Unexpectedly Pik3r1 protein 
levels were not altered and Tsc1 protein levels were inversely correlated to Tsc1 
transcript levels. Nevertheless Tsc1 protein up-regulation was consistent with an 
attenuating effect of miR-183 and miR-378 on mTOR signaling and adipocyte marker 
transcript levels. Since miRNA-mediated effects were detected during the late stages of 
differentiation, these miRNAs may be involved in negative feedback regulatory 
mechanisms. We found that miR-107 and miR-182 reduced lipid droplet size during 
adipocyte differentiation. The present study provides first experimental evidence for the 
predicted effects of miRNA family 103/107 on lipid metabolism. Moreover, our data are 
suggestive that miRNA families may exhibit further effects on adipogenesis additionally 
to those of the respective single miRNAs. 
Especially the effect of miR-107, miR-182 and miRNA family 103/107 on adipocyte 
differentiation makes them promising targets for further investigation. Above all the 
attenuating effect of miR-183 and miR-378 on mTOR signaling as well as adipocyte 
differentiation may also suggest an utility of these miRNAs as biomarkers for nutrient-
driven dysregulation of adipogenesis. 
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G Appendix 
1. Supplementary data 
Table S 1 In silico mTOR target prediction of rapamycin-sensitive miRNAs 
MiRNAs with confirmed differential expression on day 8 of differentiation in the presence or 
absence of rapamycin were subjected to a stringent in silico target prediction. Five different 
prediction algorithms were used (PITA, miRanda, TargetScanS, PicTar and TargetSpy) and 
only miRNA-target pairs with a consensus prediction of at least 2 algorithms were 
considered predicted. MiRNA members of cluster 183/96/182 and family 103/107 are 
highlighted. ‘Rapamycin effect’: log2 fold change (day 8 rapamycin treatment versus day 8 of 
differentiation experiments).  
microRNA rapamycin 
effect 
Predicted mTOR pathway target genes 
miR-182 -3.06 Mapk1, Pik3r3, Rictor 
miR-96 -2.90 Akt3, mTOR, Rptor, Rictor, Rps6ka6 
miR-183 -2.70 Rps6ka2, Tsc1 
miR-378 -2.12 Akt1, Mapk1, Cab39, Tsc1 
miR-103/107 -1.66/-2.10 Eif4b, Cab39, Pik3cb, Pik3r1, Vegfa 
miR-143 -0.83 Eif4b, Pik3cg, Pik3r3, Rps6ka1, Rps6ka2 
miR-30a -0.82 Prkaa2, Cab39, Pik3cd, Pik3r2, Ddit4, Rictor, 
Rps6kb1 
miR-494 -0.76 Akt1, Akt3, Prkaa2, Ulk2, Igf1, Mapk1, Cab39, 
Pik3cb 
miR-340-5p -0.72 Akt3, Hif1a, Igf1, Rps6kb1 
miR-29a 0.65 Akt3, Eif4e2, Igf1, Pik3cg, Pik3r1, Pik3r3, Rptor, 
Vegfa 
miR-503 1.01 Akt3, Eif4b, Eif4e, Rictor, Vegfa 
miR-125b-5p 1.03 Eif4ebp1, Rps6ka1, Vegfa 
miR-199a-3p 1.06 Hif1a, mTOR, Pik3cd, Rheb, Rps6kb1 
miR-214 1.06 Akt2, Akt3, Ulk1, Eif4b, Igf1, Cab39, Pik3cb, 
Pik3r3, Rictor, Rps6ka1, Vegfa 
miR-222 1.61 Prkaa2, Pik3r1, Ddit4, Rps6kb1, Tsc2 
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Figure S 1: Plasmid map of psiCHECKTM-2 Vector  
3’UTRs of predicted target genes were cloned into NotI and AsiI restriction sites. (From 
Technical Bulletin of siCHECKTM Vectors, Promega, Wisconsin, USA). 
 
 
Figure S 2: Rapamycin-dependent miRNA expression changes during 3T3-L1 
adipogenic differentiation 
‘Rapamycin effect’: log2 ( fold changeday 8 with rapamycin -  fold changeday 8). Previous study: 
RNA of 2 independent experiments was isolated at day 0 and day 8 of differentiation with 
and without rapamycin treatment and quantified using miRNA microarray. Current study: 
RNA of 2 independent experiments was isolated at day 0 and day 6 of differentiation with 
and without rapamycin treatment and quantified using rt-PCR.  
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Figure S 3: Cell viability in transfection experiments 
Graph shown percentage of dead cells measured via flow cytometry. 3T3-L1 pre-adipocytes 
were transfected with a labelled siRNA or an un-labelled control miRNA and stained with 7-
AAD. (A) Cells were transfected with 20 pmol labelled siRNA/control miRNA and harvested 
at different time points post transfection. (B) Cells were transfected with different 
concentrations of labelled siRNA and harvested 24 hours post transfection. Mean values ± 
S.E.M. of 2 independent experiments. 10,000 cells were analyzed for each treatment group. 
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Figure S 4: Flow cytometry of transfected 3T3-L1 pre-adipocytes 24, 48 and 72 hours 
post transfection 
(A) Representative flow cytometry plots show intracellular AF-488 versus 7-AAD staining. 
Representative histograms indicate analyzed events versus (B) AF-488 or (C) 7-AAD 
intensity in 3T3-L1 cells transfected with an AF-488-labelled siRNA 24, 48 and 72 hours post 
transfection. Cells were transfected with 20 pmol siRNA per well. Control cells were 
transfected with an unlabelled control miRNA. Numbers in plots and histograms stand for the 
percentage of cells in the gated population. 
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Figure S 5: Flow cytometry of 3T3-L1 pre-adipocytes transfected with 10, 20 and 
40 pmol AF-488-labelled siRNA 
(A) Representative flow cytometry plots show intracellular AF-488 versus 7-AAD staining. 
Representative histograms indicate analyzed events versus (B) AF-488 or (C) 7-AAD 
intensity in 3T3-L1 cells transfected with 10, 20 and 40 pmol AF-488-labelled siRNA per well. 
Cells were harvested 24 hours post transfection. Control cells were transfected with an 
unlabelled control miRNA. Numbers in plots and histograms indicate the percentage of cells 
in the gated population. 
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Figure S 6: MiRNA effects on target transcript levels during 3T3-L1 adipogenic 
differentiation 
Transcript levels were quantified using rt-PCR in 3T3-L1 cells transfected with different Pre-
miRTM miRNA Precursors and subsequently differentiated. (A) Tsc1 (B) Pik3r1 and (C) 
Pik3r3 transcript levels are shown. Gene expression was normalized to the respective 
expression levels in control cells at day 0 of differentiation. Mean values ± S.E.M. of 2 
independent experiments each performed in technical triplicates. 
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Figure S 7: Increase in miR-183 and -378 expression during the late phase of 3T3-L1 
adipogenic differentiation 
Rt-PCR quantification of miRNA levels over 8 days of differentiation. Expression changes of 
(A) miR-183 and (B) miR-378 levels, normalized to day 0 expression are shown. Mean 
values ± S.E.M of 2 independent experiments, each performed in technical triplicates. 
Asterisks show significant regulation as compared to day 0. *** P ≤ 0.001.  
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2. List of abbreviations 
7-AAD  7-amino-actinomycin D 
Actb  beta actin 
Akt  v-akt murine thymoma viral oncogene 
(c)AMP  (cyclic) adenosine monophosphate 
Ampk  AMP-activated protein kinase (gene name Prkaa2) 
bp  base pair 
BMI  Body Mass Index 
BSA  bovine serum albumin 
Cab39  calcium binding protein39 
C/ebp  CCAAT/enhancer binding protein 
Ddit  DNA-damage-inducible transcript 
Dlk1  delta-like 1 homolog 
DMEM  Dulbecco’s Modified Eagle Medium 
DMSO  dimethyl sulfoxide 
DNA  deoxy ribonucleic acid 
dNTP  deoxy nucleoside triphosphate 
DTT  dithiothreitol 
4Ebp1  eukaryotic translation initiation factor 4E binding protein 1 
EDTA  ethylenediaminetetraacetic acid 
eIF4a/b/e/g  eukaryotic translation initiation factor 4A/B/E/G 
eIF4ebp1  eukaryotic translation initiation factor 4E binding protein 1 
Exp-5  Exportin-5 
FACS  Fluorescence-activated cell sorting 
FBS  Fetal Bovine Serum 
Fkbp12  FK506-binding protein 12 
Gβl  G-protein beta-subunit-like 
Hif1  hypoxia inducible factor 1 
Hprt  hypoxanthine guanine phosphoribosyl transferase 
IBMX  3-Isobutyl-1-methylxanthine 
Igf  insulin-like growth factor 
KEGG  Kyoto Encyclopedia of Genes and Genomes 
LB-Amp100   Luria Bertani medium containing 100 µg/ml ampicillin 
LDA  Low density array 
M  Molar 
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Mapk  mitogen-activated protein kinase 
miR/miRNA  microRNA  
mTOR  mammalian target of rapamycin 
mTORC1/2  mammalian target of rapamycin complex 1/2 
PBS  Phosphate buffered saline 
Pfu  Pyrococcus furiosus 
Pho  phosphate 
Pik3r1  phosphatidylinositol 3-kinase regulatory subunit 1 (alpha) 
Pik3r3  phosphatidylinositol 3-kinase regulatory subunit 3 (gamma) 
Pparγ  Peroxisome proliferator-activated receptor gamma 
Ppib  peptidylprolyl isomerase b (cyclophilin B) 
Pref-1  pre-adipocyte factor-1 
pre-miRNA  precursor microRNA 
pri-miRNA  primary microRNA 
Prkaa2  AMP-activated protein kinase alpha 2 catalytic subunit 
Rheb  Ras homolog enriched in brain 
Rictor  Rptor independent companion of mTOR complex 2 
RISC  RNA-induced silencing complex 
Rn18s  18S ribosomal RNA 
Rps6ka  p90 ribosomal protein S6 kinase 
Rps6kb  p70 ribosomal protein S6 kinase 
Rptor  regulatory associated protein of mTOR complex 1 
Rsk  p90 ribosomal protein S6 kinase 
RT  Reverse Transcription 
rt-PCR  real-time PCR 
S6k1  p70 ribosomal protein S6 kinase 1 
SDS software  Sequence Detection Systems software 
SDS  sodium dodecyl sulfate 
TAE  Tris-acetate-EDTA 
TRIS  Tris (hydroxymethyl)-aminomethan 
Tsc1/2  tuberous sclerosis protein 1/2 
Ube2d2  ubiquitin-conjugating enzyme E2D2A 
Ulk  Unc-51like kinase 
UTR  untranslated region 
Vegfa  vascular endothelial growth factor A  
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